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INTRODUCTION 
The chemical structure of the phenanthridinium 
compounds is shown in Figure 1. The biological properties 
of these compounds, as well as the physicochemical effects 
of one of them, ethidium bromide (3.8-diamino-5-ethyl-6-
phenyl phenanthridinium bromide), (usually abbreviated EB), 
on nucleic acids have been the subject of intense investi-
gation in the past two decades. 
,· 
Studies of the properties of phenanthridinium ·· 
compounds have been carried out by two distinct approaches. 
Initially, the biological effects of these compounds were 
studied, occasionally as a function of their chemical 
structure. In contrast, during the past ten years, research 
in this subject has been increasingly oriented towards the 
physicochemical properties of the complexes of EB with 
nucleic acids. 
1. Biological activity of phenanthridinium compounds 
Phenanthridinium compounds were first found to 
possess antitrypanosomal activity in 1938 (Browning, 1938). 
Later, they were also found to act as antibacterial (Seaman 
and Woodbine, 1954) and antiviral agents (Dickinson et al., 
1953). 
The in vivo antitrypanosomal activity of the best 
studied phenanthridinium drug, ethidium bromide, is observed 
1 
2 
Figure 1. General formula of the phenanthridinium 
compounds. The compounds used in this study have the follo-
wing substituents: 
EB: R1 = R4 = NH2 , Rz = ethyl, R3 = phenyl. 
DDMB: Rl = R4 = NHz, R2 = R3 = methyl. 
DEMB: Rl = R4 = NH2 , Rz = methyl, R3 =·ethyl. 
MAPAC: Rl = H, ~~Rz = allyl, R3 = Q-aminophenyl, 
MAPEC: Rl = H, Rz = ethyl, R3 = Q-aminophenyl, 
R4 
R4 
MMPB: Rl = H, R2 = methyl, R3 = phenyl, R4 = NH2 . 
1 
6 5 
-N 
+'R2 
= NHz. 
= NH2. 
p 
3 
as a decrease in the number of trypanosomes in the blood 
of infected animals. This decrease is not immediate upon 
exposure to EB, but it is preceded by a lag phase of approxi-
mately 3 to 4 days (Hawking and Sen, 1960). As early as 4 
hours after contact with the drug, however, basophilic 
granules, consisting mainly of nucleoprotein, are observed 
in the cytoplasm of the trypanosomes (Ormerod, 195lb). 
These granules do not immediately influence the development 
of the organisms, which, 24 hours after exposure to the drug, 
are still actively multiplying. The cell division rate, 
however, later declines and, after more prolonged contact 
with EB, an increased number of multinucleate and a decrea-
sed number of dividing forms are observed (Ormerod, 195lb; 
Ormerod, 1961). 
Analogous morphological alterations in the kineto-
plasts of trypanosomes grown in the presence of EB in vitro 
have been reported (Riou, 1967a). 
Similar effects are also observed when Crithidia 
oncopelti are exposed to EB in vitro. Ribonucleoprotein 
granules appear in the cytoplasm but multiplication of the 
organisms is not inhibited until at least one cycle of 
division has been completed (Newton, 1957). It was also 
noted that transfer of the organisms to a drug-free medium, 
after their multipli~ation had been inhibited by EB, did 
not restore their ability to multiply. However, if the 
4 
organisms' exposure to the drug was terminated before their 
multiplication was completely inhibited, they continued to 
grow and multiply, albeit at decreased rate. It is interes-
ting to note that the decrease in the multiplication rate is 
proportional to the organisms' exposure to the drug. 
These findings, along with the.observation that~ 
oncopelti maintained in a non growth-supporting medium, 
exposed to EB and later transferred to a drug-free growth-
supporting medium grew at a normal rate (Newton, 1957), 
indicate that growth in the presence of EB is an essential 
condition for the lethal action of the drug. 
Morphological and physiological alterations in the 
presence of EB, similar to those produced in trypanosomes, 
are also observed in other systems, such as algae; swelling 
of the chloroplasts and decomposition of the organelles' in-
ternal membrane systems is reported as a result of growth in 
the presence of EB (Heilporn and Limbosch, 1971). Similar-
ly, EB causes morphological alterations of the smooth endo-. 
plasmic reticulum and the mitochondria in various lines of 
mammalian cells. These changes are accompanied by reduction 
and eventual disappearance of several respiratory enzymes 
(Nass, 1970; Naum and Pious, 1971; King et al., 1972). 
On the molecular level, considerable evidence has 
been accumulated suggesting that EB interferes with the meta-
bolism of nucleic acids. As early as 1957 it was reported 
5 
{Newton, 1957) that DNA synthesis is drastically inhibited 
in ~ oncopelti grown in vitro in the presence of EB. More 
recently, EB was found to inhibit host cell mediated re-
activation of UV-irradiated phage in bacteria (Shankel and 
Molholt, 1973) and to block RNA synthesis in mammalian cells 
{Watts, 1970). 
An interesting aspect of the in vivo action of EB is 
that it is generally directed selectively against non-nuclear 
DNA. This selectivity is not limited to certain organism~ 
only but appears to span a wide range of the phylogenetic 
spectrum. For example, in the presence of low concentra-
tions of EB, mitochondrial DNA synthesis is selectively .in-
hibited in both yeast and mammalian cells and the preexisting 
mitochondrial DNA of the yeast is degraded (Goldring et al, 
1970; Goldring et al., 1971; Radsak et al;, 1971). Also, 
growth of trypanosomes in the presence of EB results in 
selective inhibition of kinetoplastic DNA synthesis (Riou, 
1967b; Delain and Riou, 1969) accompanied by the appearance 
of abnormal oligomeric circular DNA molecules. in the kineto-
plast (Riou and Delain, 1969). 
From these and other similar observations, the hypo-
thes~s was developed that the primary in vivo target of EB is 
the metabolism of nucleic acids. This hypothesis was further 
supported by in vitro experiments indicating that EB inhibits 
the action of pancreatic deoxyribonuclease (Eron and McAuslan, 
1966), ~coli and mammalian DNA polymerases (Elliott, 
\ 
6 
l963; Meyer and Simpson, 1969), ~· coli RNA polymerase 
(Waring, 1965a) and RNA-dependent DNA polymerase from the 
Rauscher murine leukaemia virus (Muller et al., 1971). 
A number of attempts have been made to establish a 
relationship between the trypanocidal activity and the mole-
cular structure of phenanthridinium compounds. It appears 
that antitrypanosomal activity requires at least one primary 
amino substituent on the phenanthridinium nucleus; a second 
amino substituent further enhances trypanocidal activity 
{Walls, 1945; Walls, 1947; Brownlee et al., 1950). The 
size of the quaternizing alkyl group at position 5 of the 
ring seems also to be important for activity; antitrypano-
somal activity increases with the length of the alkyl group 
for up to 3 carbon atoms and then decreases with increasing 
length of the chain (Woolfe, 1952; Woolfe, 1956). 
2. Physicochemical properties of the phenanthridinium-DNA 
complex 
Investigation of the physicochemical properties of 
the phenanthridinium-DNA complex has been, almost exclusive-
ly, limited to the study of the properties of the EB-DNA 
complex. Ethidium bromide forms complexes with double-stran-
ded DNA and RNA (Waring, 1965b; Douthard et al., 1973) in 
which the dye is strongly bound to the polynucleotide. The 
nucleic acid-bound EB cannot be removed by dialysis (Waring, 
1965b) but the complex is easily dissociated if passed 
\ 
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through an ion-exchange column {Fuller and Waring, 1964; 
Radloff et al., 1967). 
The formation of a complex between EB and nucleic 
acids causes a metachromatic shift in the absorption maximum 
of the dye from 480 nm to approximately 518 nm (Elliott, 
1963; Waring, 1965b). On the basis of this observation, 
the binding of EB to DNA can be studied and the equilibrium 
parameters determined by using the Scatchard relation 
"£1£ =Kn - Kr (Scatchard, 1949). The base composition of the 
nucleic acid does not seem to affect significantly the extent 
of binding or the properties of the dye (Waring, 1965b; 
LePecq and Paoletti, 1967). 
'Scatchard plots obtained at low ionic strength from 
spectrophotometric titration of EB with double-stranded 
nucleic acids consist of two intersecting· straight lines 
(Waring, 1965b; Douthard et al., 1973) indicating that two 
distinct bindi'ng processes are taking place. These are 
usually referred to as primary and secondary binding, the 
primary being the stronger of the two. 
It is generally accepted that the primary binding in-
volves intercalation, i.e. positioning of the planar dye 
molecule between adjacent base pairs so that the plane of 
the ring is approximately perpendicular to the axis of the 
helix. The intercalation model was first proposed by Lerman 
(Lerman, 1961) to explain the binding of aminoacridines 
to DNA. In the case of EB, the forces stabilizing this 
\ 
\ 
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complex are mainly hydrophobic interactions between the 
DNA base-pairs and the phenanthridiniurn ring system, as 
suggested by the observation that ethanol dissociates the 
complex (Fuller and Waring, 1964). Also, since the binding 
of EB to DNA decreases with increasing ionic strength 
(LePecq and Paoletti, 1967), hydrogen bonds, which can be 
formed between ethidiurn amino groups and the negatively 
charged phosphates of the DNA backbone, may also contribute 
to the stabilization of the complex (Fuller and Waring, 
1964). 
The complex of ethidiurn bromide with double-stranded 
nucleic acids exhibits physicochemical properties which are 
consistent with intercalation, specificallys 
1. The intercalation model requires that the plane 
of the bound drug molecules be parallel to that of the base 
pairs, i.e. perpendicular to the helix axis. Experimental 
results indicating such an orientation of the bound molecule 
were obtained by the use of flow dichroism and fluorescence 
polarization techniques (LePecq and Paoletti, 1967). 
2. A second consequence of intercalation is the 
increase in the legnth of DNA as the helix unwinds to acco-
modate drug molecules. This increase has been noticed by 
electron microscopy (Freifelder, 1971). Indirect proof for 
this length increase is also provided by the observation 
that the intrinsic viscosity of double-stranded DNA or RNA 
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solutions increases significantly in the presence of EB 
(LePecq, 1965; Douthard et al., 1973). 
3. The length increase in DNA due to intercalation 
is expected to result in decreased length-specific mass of 
the polynucleotide because the additional length due to each 
EB molecule is about the same as that of a nucleotide pair 
(mean molecular weight = 650), while the mass increment 
(molecular weight of the ethidium free base = 315) is less 
than one-half of that of a nucleotide pair. This decrease 
in length-specific mass is observed as a decrease in the 
sedimentation coefficient of the nucleic acid in the presen-
ce of the dye (LePecq, 1965; Douthard et al., 1973). 
4. Upon binding to double-stranded DNA, the quantum 
efficiency of the EB fluorescence increases dramatically. 
No increase in fluorescence is noted, however, with single-
stranded DNA (LePecq and Paoletti, 1967). Ethidium mole-
cules intercalated in double-stranded DNA are placed in an 
environment of considerably lower dielectric constant 
(Gersch and Jordan, 1965) than the environment of the unbound 
dye, which may explain the observed fluorescence enhancement. 
5. The effect of phenanthridinium compounds on 
covalently closed circular DNA constitutes perhaps the most 
convincing evidence in favor of the intercalation model. It 
was found that exposure of supercoiled DNA to increasing 
amounts of EB reduc'es its sedimentation velocity until it is 
equal to that of nicked circular DNA. Addition of larger 
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amounts of EB results in an increase of the sedimentation 
velocity of supercoiled DNA. In contrast, the sedimentation 
velocity of nicked circular DNA exhibits a monotonic de-
crease with increasing concentration of EB (Crawford and 
Waring, 1967; Bauer and Vinograd, 1968). These findings 
were interpreted as indicative of loss and subsequent rever-
sal of the supercoiling turns of the DNA as a result of the 
local unwinding of the double helix, due to intercalation of 
the drug. Similar observations were also made with various 
EB analogues, indicating that the primary amino groups at 
positions 3 and 8 of the phenanthridinium ring are not man-
datory for intercalation, although derivatives lacking the 
3-amino substituent exhibit a slightly lower unwinding angle 
than the 3.8-diamino derivatives (Wakelin and Waring, 1974). 
The angle of double-helix unwinding.upon EB inter-
calation was estimated by measuring the fluorescence depola-
o . 
rization of the EB-DNA complex to be approximately 12 per 
intercalated EB molecule (Pigram et al., 1973). This value 
agrees with that originally proposed (Fuller and Waring, 
1964) on the basis of model-building studies and X-ray crys-
tallographic data, although, according to more recent evi-
dence, the angle of unwinding may be as high as 26° per 
intercalated molecule (Wang, 1974). 
Secondary binding between EB and double-stranded DNA 
is observed at relatively high added EB/DNA ratios and low 
ionic strengths. This binding is believed to arise mainly 
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from electrostatic interactions between the DNA phosphate 
residues and EB molecules attached to the outside of the 
helix. Increased ionic strength eliminates secondary bin-
ding, as evidenced from the straight-line Scatchard plots ob-
tained under high ionic strength conditions (Waring, 1964; 
Waring, 1965b). 
3. The scope of this investigation 
As mentioned earlier in this Section, a number of 
attempts have been made to determine the relation between the 
exact chemical structure of phenanthridinium drugs and their 
pharmacological properties. The in vivo experiments perfor-
med so far have provided information as to the biological 
activity of these compounds. However, in such experiments a 
large number of parameters, such as in vivo stability of the 
drugs, permeability of the cell membranes to the drugs, selec-
tive binding of the drugs by various components of the blood, 
etc. are involved. Since in the in vivo experiments these 
parameters cannot be easily controlled, only empirical deter-
minations of an overall structure-function relationship can, 
at best, be obtained by in vivo studies. Such experiments, 
however, provide little information about the existence and 
nature of any such relationship· on the molecular level. 
As previously indicated, biological properties of 
EB originate from the interaction of this compound with DNA 
(see, inter alia, Newton, 1957; Delain and Riou, 1969; 
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Goldring et al., 1970). It is therefore reasonable to 
assume that the specificity of action of the phenanthridinitun 
drugs depends on the physical consequences of the DNA-drug 
binding. The interaction of EB with DNA influences both the 
conformation and the stability of double-stranded DNA and 
may, as a result, determine the functi0n of DNA as template 
during replication and transcription. 
In spite of accumulating information on the nature of 
the interactions between EB and DNA, no successful attempts 
has yet been made to account for the biochemical and pharma-
cological properties of the phenanthridinitun drugs on the 
basis of the physicochemical properties of the DNA-phenan-
thridinitun complex. This investigation was, therefore, under-
taken as an attempt to answer two interrelated but distinct 
questions, namely: 
A. Does the chemical structure of the intercalated 
drug molecule affect the overall conformation and stability 
of the drug-DNA complex and, if so, to what extent7 and 
B. If such a change in the confonnation of the com-
plex occurs, how does this change influence the function of 
the complex with respect to its role in nucleic acid meta-
bolism. Specifically, how is the ability of the complex to 
function as a substrate or as a template for deoxyribonuclease 
I and DNA polymerase I affected by the specific three-dimen-
sional structure of the complex'? 
MATERIAL AND METHODS 
I. MATERIALS 
Calf thymus deoxyribonucleic acid was purchased from 
Worthington Biochemical Corp., Freehold, New Jersey. 
Salmon sperm deoxyribonucleic acid was obtained from 
Nutritional Biochemical Corp., Cleveland, Ohio. 
Deoxyribonuclease I from beef pancreas (Deoxyribo-
nucleate oligonucleotide-hydrolase; E.C. 3.1.4.5.) was ob-
tained from Sigma Chemical Co., Saint Louis, Missouri 
(Lot number 20C-1810, prepared chromatographically; supplied 
as a lyopnilized powder, 2000 Kunitz units/mg; one Kunit.z 
unit will cause the absorbance at 260 nm of a DNA solution 
to increase at a rate of 0.001 per ml at 25°~). 
DNA polymerase I, from Micrococcus luteus (Deoxyribo-
nucleosidetriphosphate: DNA deoxynucleotidyl transferase; 
E.C. 2.7.7.7.)'was obtained from Sigma Chemical Co., Saint 
Louis, Missouri (Lot number 63C-2810, prepared by column 
chromatography o~ DEAE cellulose and gel filtration media; 
supplied as a lyophilized powder, ·12.5 units per mg of 
protein; one unit will incorporate 10 nanomoles of total 
nucleotide into an acid insoluble product in 30 min at 
pH 7.0 at 37°C, using calf thymus DNA as template). 
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Ethidiwn bromide (3,8-diamino-5-ethyl-6-phenylphenan-
thridiniwn bromide) was obtained from Calbiochem, Los 
Angeles, California, Lot nwnber 100301. 
Crystalline samples of the following phenanthridiniwn 
compounds were kindly provided by Dr. T. I. Watkins (Boots 
Pure Drug Co., Ltd., Great Britain): 
3,8-diamino-5,6-dimethylphenanthridinium bromide (DDMB), 
3,8-diamino-6-ethyl-5-methylphenanthridiniwn bromide (DEMB), 
8-amino-6-p-aminophenyl-5-ethylphenanthridinium chloride 
(MAPEC), 
5-allyl-8-amino-6-p-aminophenylphenanthridiniwn chloride 
(MAPAC), and 
8-amino-5-methyl-6-phenylphenanthridiniwn bromide (MMPB). 
These derivatives were used without further purification. 
Sodiwn salts of deoxyribonucleotide triphosphates 
(TIP, dGTP, dCTP and dATP) were obtained from Worthington 
Biochemical Corp., Freehold, New Jersey. 
Tritiated TIP was purchased from New England Nuclear, 
Boston, Massachusetts (tetrasodiwn salt, specific activity 
40 Ci/mmole) and from Schwartz/Mann, Orangeburg, New York 
(tetralithiwn salt, specific activity 54 Ci/mmole). 
Other chemicals used in these studies were of analy-
tical reagent grade. 
II. INSTRUMENTS 
In these studies the following instruments were used: 
Cary 15 recording spectrophotometer, Cary Instrument 
Corp. 
Durrum-Jasco ORD/UV-5 recording spectropolarimeter, 
Durrum Instrument Co. The instrument was modified to a maxi-
mum sensitivity of 0.002 degrees of ellipticity per cm 
(SS-10 modification). 
Aminco-Bowman spectrophotofluorimeter (Model 4-8202 
SPF) with a ratio photometer (Model 4-8912), American Instru-
ment Co., connected to an Omnigraphic 2000 X-Y recorder, 
Houston Instrument. 
Tm Analyzer and Temperature Bridge, Beckman Instru-
ment Inc., connected to a Moseley 7035B X-Y recorder, 
Hewlett Packard Corp. 
Beckman LS-250 Liquid Scintillation Counter. 
Lauda K-2/R Constant Temperature Circulator, 
Brinkman Instruments. 
16 
III. METHODS 
1. Preparation of stock solutions 
The buffer used in these studies, unless otherwise 
specified, was 0.04 tl Tris-HCl, pH 7.9. For experiments 
carried out at higher ionic strengths, NaCl was added to the 
composition of this buffer so that the final salt concen-
tration ranged between 0.025 and 5.0 M. 
Calf thymus DNA was dissolved (4 mg/ml) in Tris-
HCl buffer after slow stirring in the cold for approximately 
24 hours and then dialyzed twice against 20 volumes of the 
same buffer for 48 hours. This stock solution of DNA was 
then kept in the refrigerator at 4°C. 
Before every experiment, an amount of the DNA stock 
solution was diluted with buffer to give a working solution. 
The DNA phosphate concentration of this solution was deter-
mined spectrophotometrically using an extinction coefficient 
at 260 nm of 6600 (Mahler et al., 1964). 
Ethidium bromide solutions were prepared by dissol-
ving the salt into the buffer. The final concentration was 
determined spectrophotometrically using an extinction co-
efficient at 480 nm of 56QO (Waring, 1965a). 
The wor~ing solutions of the other phenanthridinium 
compounds were prepared by dissolving a weighed amount of the 
corresponding salt into the appropriate volume of buffer. 
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The molar concentrations were calculated on the basis of the 
amount weighed and the formula weight of the compound. From 
these preparations, the following extinction coefficients 
were estimated: DDMB: 4140 at 463 nm; DEMB: 4740 at 465 nm; 
MAPAC: 4750 at 438 nm; MAPEC: 5100 at 430 nm; MMPB: 3255 
at 430 nm. 
All the phenanthridinium salt solutions were kept in 
the dark until they were used. 
2. Preparation of the complex 
Complexes of various added dye/nucleotide molar 
ratios were prepared at a constant dye concentration and 
varying DNA concentrations. Typically, 2 ml of the dye solu-
tion were mixed with varying volumes of the DNA working solu-
tion and buffer was added to a final volume of 10 ml. In 
certain cases, however, as indicated, the reverse procedure 
was used, i.e. the DNA concentration was kept constant and 
the dye concentration was varied. 
3. Binding determination 
For the determination of the amount of dye bound to 
DNA, the spectrophotometric method of Peacocke and Skerett 
(Peacocke and Skerett, 1956) was used. The method is based 
on the bathochromic shift in the dye absorption spectrum 
upon binding to DNA. 
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According to this method, if: 
1. DNA does not absorb in the wavelength region usedJ 
2. Both free and bound dye obey Beer's law over the 
range of concentrations used for the binding studies; 
3. The extinction coefficient of the bound dye is 
independent of the dye/DNA ratio; 
4a. The bound dye is present as a single species so 
that the maximum number of species present, including the 
free dye, is two; or 
4b. If more than one species with different spectra, 
apart from the free dye, are present, the relative propor-
tion of these does not vary with the dye/DNA ratio, then, 
an isosbestic point, through which all spectra of samples 
containing a constant dye concentration and varying DNA con-
centrations would pass, is defined. 
Under these copditions, the fraction, b, of dye bound 
to DNA can be calculated from the equation: 
b = 
Ar - A 
A Ax (Eqn. 1) 
f - b 
where Af is the absorption of the free dye, Ab is the absorp-
tion of the bound dye, an Ax is the absorption of the unknown 
sample at any one wavelength. Equation 1 is valid at all 
wavelengths where the above mentioned conditions are satisfied. 
However, for increased accuracy, b is calculated at the 
wavelength where the difference Af - Ab is maximum. 
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If the fraction, b, of DNA-bound dye is known, then 
£ is defined as the molar ratio of DNA-bound dye per DNA 
phosphate. 
4. Circular dichroism measurements 
Circular dichroism spectra were recorded using the 
Jasco spectropolarimeter. Measurements were carried out in 
cells with light paths ranging from 0.1 to 10.0 cm, so that 
absorbances remained below 2.0. This precaution was taken 
because optical artifacts may be observed at absorbance 
values above this limit. 
Circular dichroism values are reported as molar 
ellipticities (E 1 - Er)' which were calculated from the 
equation: 
E: _ E = Degrees of ellipticity (E n. 2) 
1 r 33 x c x 1 · q 
where "Degrees of ellipticity" are obtained directly from· 
the recorder chart, the concentration, c, is expressed in 
moles per litre, and the light path of the cell, 1, is 
expressed in centimetres. In the calculation of the €1 - ~r , 
the concentration of DNA-bound raLher than "total added" 
dye was used, except as otherwise specified. 
The spectropolarimeter was standardized with a 
solution of d-10-camphosulphonic acid (1.0 mg/ml, supplied 
by Durrum Instrument Co.). The standard solution has an 
ellipticity of +0.313 degrees at 290 nm. The instrument 
was calibrated so that the solution causes a 15.65 cm 
deflection on the 0.02 degrees/cm scale. 
5, Fluorescence measurements 
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Fluorescence measurements were obtained using the 
Aminco-Bowman spectrophotofluorimeter. Cells with four 
optically polished windows and 1.0 cm rectangular cross 
section were used. 
Excitation and emission fluorescence spectra were 
recorded on the Omnigraphic X-Y recorder with the X axis 
calibrated to read wavelength and the Y axis to correspond 
to the relative intensity reading of the Ratio Photometer. 
for: 
The intensity values thus obtained were corrected 
1. Fluorescence contribution of the free dyes fluo-
1 
rescence intensity proportional to the concentration of the 
free dye was substracted. 
2. Absorption of the excitation light by the sample; 
since fluorescence is measured at the middle of a 1.0 cm. 
cell, the correction factor is the decimal antilogarithm of 
half the absorbance of the sample at the excitation wave-
length. 
No correction for absorption of the emission light 
was made, since neither the free nor the bound dye absorb 
appreciably at the emission wavelength. 
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Fluorescence values were plotted as "Net molar 
fluorescence", which was calculated from the Equation: 
Net 
molar 
fluo- = 
resc-
ence 
A 
robs' x antilog z - Molar fluorescencef x Df (Eqn. J) 
Db 
where: robs is the observed fluorescence; A is the absorbance 
of the sample at the excitation wavelength; Molar fluores-
cencef is the fluorescence intensity per mole of free dye; 
Df is the free dye concentration; and Db is the bound dye 
concentration. 
6. Elevated temperature measurements 
For the study of the dependence of absorbance on 
temperature, a thermostated cell holder was used in connec-
tion with the Beckman Tm Analyzer and Temperature Bridge. 
With the use of these instruments the temperature of 
the sample can be linearly increased at a programmed rate. 
The rate used was 3°C/min unless otherwise specified. The 
temperature of the sample was monitored using a platinum 
resistance probe which produces a linear change in resistance 
with temperature. The probe is immersed in a reference cell 
which is being heated at the same rate as the sample-con-
taining cell. The probe is connected to the Temperature 
Bridge, which converts the temperature-dependent resistance 
of the probe to a linear 10 mV output signal. 
For the recording of absorbance at a given wavelength 
versus temperature, the Moseley X-Y recorder was used with 
the X axis calibrated to read temperature and the Y axis to 
correspond to the position of the pen of the spectrophoto-
meter. The X signal was obtained directly from the Tempera-
ture Bridge. The Y signal was obtained from a potentiometer 
installed on the pen-drive shaft of the spectrophotometer. 
This signal was mediated by a custom-made calibration box 
(Martz and Aktipis, 1971) which provides for expansion and 
baseline adjustment of the scale. 
Melting profiles of DNA and DNA-drug complexes were 
plotted as normalized hyperchromicity versus temperature. 
Normalized hyperchromicity is the hyperchromicity expressed 
as percent of the final hyperchromicity value observed at 
the end of the transition. Tm, then, is defined as the tem-
perature at which a normalized hyperchromicity value of 50% 
is observed. ~T30 _ 70 is a measure of the width of the mel-
ting transition and represents the difference, in degrees, 
between the temperatures at which 30% and 70%, respectively, 
of hyperchromicity is observed. 
7. Deoxyribonuclease assay 
The assay for DNase activity used was essentially that·· 
of Lindberg (Lindberg, 1964) with minor modifications. The 
method is based on the measurement of DNA hyperchromicity 
at 260 nm as the polynucleotide is hydrolyzed. 
r 
r 
f 
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The assay was performed, at room temperature, as 
follows: 
A 3 ml aliquot of a DNA solution (0.15 mM) was added 
into a tube containing 1 ml of drug solution (or buffer, in 
the case of control). The contents of the tube were mixed 
and left standing for approximately 1 min. Subsequently, 
0.03 ml of the enzyme solution (0.1 mg/ml) were added, the 
tube was covered with parafilm and inverted rapidly 3-4 
times; the contents of the tube were then poured into a 
1.0 cm cuvette and monitoring at 260 nm begun, generally 
within 15 - 20 seconds after the addition of the enzyme. 
The assay mixture had the following composition: 
0.04 tl Tris-HCl, pH 7.9, 0.004 ~ MgS04, 0.0017 tl CaCl2, 
0.00011 M calf thymus DNA, and 0.75 µg/ml enzyme. 
The hyperchromicity at 260 nm exhibits an initial 
lag phase of approximately 20 sec., after which the absor-
bance increases linearly with time for at least 50 sec. 
This lag phase is due to the fact that the first few phos-
phate bonds to be hydrolyzed are statistically situated far 
apart from one another and, therefore, do not cause the 
release of any hyperchromic material. 
For the calculation of the initial reaction rates, 
the linear part of the absorbance versus time plot, which. 
follows the lag phase, was used. 
Hyperchromicity at 260 nm during enzymatic degrada-
tion of the DNA-phenanthridinium complex is due to the 
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production of oligonucleotides, the extinction coefficient 
of which at 260 nm is higher than that of native DNA, and, 
also, to the release of intercalated molecules, which have 
a higher extinction coefficient at 260 nm in the free than 
in the bound state. 
To correct for the latter type· of hyperchromicity, 
the assay was performed as described above, but this time the 
absorption was monitored at a wavelength, A, at which DNA 
does not absorb and where the difference between the extinc-
tion coefficients of the free and the bound dye is maximum. 
For the various compounds studied, this wavelength was: EB: 
460 nm; DDMB: 450 nmi MAPEC: 425 nm; MAPAC: 430 nm. The 
corrected hyperchromicity at 260 nm is: 
6. A · A A A xA6~ 260 (Eqn. 4) 260, corr.= 0 260, obs.- 6. 
A~ 
where 6.A260 , obs. is the observed hyperchromicity at 260 nm; 
6. AA is the observed hyperchromicity at wavelength A; 6.E 260 
is the difference between the extinction coefficients of the 
free and bound dye at 260 nm; and 6.£ is the difference be-
A 
tween the extinction coefficients of the free and bound dye 
at wavelength A, 
The corrected initial velocity obtained by this 
method was used to construct the inhibition plots. In these 
plots, the function i/(l - i) (where i is the fractional in-
hibition) is plotted versus the total concentration of 
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inhibitor, Dt. It has been shown (Reiner, 1959) that when 
an inhibitor acts by decreasing the effective substrate 
concentration, a plot of Dt versus i/(l - i) yields a curve 
that passes through the origin of the axes; the initial and 
final parts of this curve are straight lines with slopes of 
y1 = K3 +St and Y2 = K3 (1+~t), respectively, where: 1 + St/K1 1 
K1 = Dissociation constant for the binding of the 
substrate to the enzyme. 
K3 = Dissociation constant for the binding of the ~ 
inhibitor to the substrate. 
St = Total substrate concentration. 
When the final linear portion of the curve is extra-
polated to the Dt axis, the intercept gives a value of St. 
By measuring the slopes of these two linear portions 
of the curve and the extrapolative inter~ept on the Dt axis, 
one can calculate the dissociation constants for the binding 
of the enzyme to the substrate and the binding of the inhi-
bitor to the substrate. 
8. DNA polymerase assay 
The method used for determining polymerase activity 
was that of Bollum (Bollum, 1966). The procedure is based 
on the incorporation of radioactivity labeled deoxyribonu-
cleotides into an acid insoluble product. 
DNA polymerase I from Micrococcus luteus was 
dissolved (0.25 mg/ml) in 0.04 ~potassium phosphate, 
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0.008 ~ MgC1 2 , pH 7.0 containing 1 mg/ml BSA and 3 mmoles/l 
2-mercaptoethanol. The mixture was subsequently divided into 
1 ml portions that were kept frozen at -20°C until they were 
used. 
The reaction mixture contained, in a final volume of 
0.3 ml, the following components at the indicated concentra-
tions: 0.04 M potassium phosphate, pH 7.0; 0.008 M MgC12 ; 
0.33 mg/ml BSA; 0.001 M 2-mercaptoethanol; 0.1 mM each of 
dATP, dGTP, dCTP; 0.1 mM of tritiated TTP {approximately 
15000 cpm/nmole); 0.072 mg/ml activated calf thymus DNA 
(see below); 0.008 mg/ml enzyme; appropriate amounts of in-
hibitor (or buffer, in the case of controL). The reaction 
was usually initiated with the addition of the nucleotide 
triphosphate (XTP) solution. On occasion, the enzyme solu-
tion was used to initiate the reaction. No significant 
difference was observed between the results of the two 
methods. 
After incubation at 37°c for 30 min, the reaction 
was stopped by immersing the test tubes containing the 
I 
reaction mixture in ice-water and adding 0.1 ml of ice-cold 
salmon sperm DNA solution (0.3 mg/ml) containing 0.1 M 
sodium pyrophosphate, followed by 0.4 ml of ice-cold 1 N 
perchloric acid containing 0.1 M sodium pyrophosphate. 
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After storing at o0 c for approximately 15 min, the tube 
contents were filtered through glass-fibre filters (Whatman 
GF/C, 2.4 cm in diameter) under mild suction. The tubes 
were subsequently washed three times with a total of 15 ml 
of 0.1 ~ HCl, 0.01 M sodium pyrophosphate and the washings 
were also filtered through the same filter. Finally, the 
filters themselves were washed twice with a total of 10 ml 
of the above solution and then with 10 ml of ethanol. The 
filters were dried for approximately 10 min at 120°C and 
counted in 10 ml of 0.4% PPO (2,5-diphenyloxazole) in to-
luene. 
In every assay, one or two samples were included, 
containing buffer instead of enzyme, for the determination 
~ 
of background radioactivity. The radioactivity of these 
samples, typically less than 2% than that.of the controls, 
was subtracted from the radioactivity of the rest of the 
assay samples. 
9. Activation of DNA 
The method used for partial digestion of DNA was 
that of Harwood et al. (Harwood et al., 1970a). The 
following solutions were used: 
A. Calf thymus DNA (2 mg/ml) in 0.01 tl Tris-HCl, 
0.005 ~ MgC12 , pH 7.8. 
B. Pancreatic DNase (6.25 pg/ml) in 0.04 M Tris-
HCl, 0.004 M MgS04 , 0.00175 M CaC12 , pH 7.8. 
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B. Pancreatic DNase (6.25 pg/ml) in 0.04 M Tris-HCl, 
0.004 M MgS04, 0.00175 M CaCl2, pH 7.8. 
The enzyme was added to the DNA solution (0.012 pg 
protein per mg of DNA) and the mixture was incubated for 10 
min at 37°C with gentle shaking. The period of 10 min was 
chosen because it coincided with maximum template activity 
of the product (Figure 2). 
The reaction was stopped by immersing the tube 
containing the enzyme-DNA mixture in ice-water and adding 
ice-cold EDTA (0.5 M, pH 8.0) to a final concentration of 
0.05 M. Subsequently, the DNA solution was extracted 4-5 
times with equal volumes of a mixture of chloroforms 
isoamyl alcohol (24: 1, v/v) and then 4-5 times with ether. 
The evaporation of residual ether was accelerated by passing 
a stream of nitrogen over the solution. 
After the extraction, the DNA solution (approximately 
10 ml) was dialyzed for 24 hours versus 4 1 of 0.01 M NaCl 
solution containing 10- 4 M EDTA, pH 7.5. This solution was 
finally divided into portions (2 ml each) which were kept 
frozen at -20°C until they were used in the DNA polymerase 
assay. 
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Figure 2. Effect of DNase digestion on templating 
efficiency of calf thymus DNA. Abscissa: time of digestion 
of DNA by pancreatic DNase I. Ordinate: radioactivity in-
corporated into acid insoluble product after incubation with 
DNA polymerase I. 
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RESULTS 
1. THE BINDING OF THE PHENANTHRIDINIUM DRUGS TO DNA 
As already indicated in the Introduction, there is 
evidence today suggesting that the biological action of the 
phenanthridinium drugs is the result of complex formation 
between these compounds and DNA. Valuable information re-
garding the nature of forces stabilizing the complex may be 
obtained by examining the effect of various substituents 
of the phenanthridinium molecule, and especially the primary 
amino groups at positions 3 and 8, on the ability of these 
compounds to bind to DNA. Furthermore, the binding studies 
provide the necessary information for the calculation of 
DNA-bound drug concentration in subsequent experiments. For 
these reasons the binding of the phenanthridinium deriva-
tives to DNA was studied under varying conditions of ionic 
strength and temperature. 
The binding of the drugs to the DNA was determined 
from the metachromatic shift observed in the spectrum of. the 
drug as a result of titration with calf thymus DNA, as des-
cribed in Section 3 (Methods). In most instances, the ab-
sorption spectra showed good isosbestic points and provided 
little, if any, evidence of drug self-aggregation. 
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1.1. Low ionic strength conditions 
Binding determinations at room temperature were per-
formed in 0.04 M Tris-HCl, pH 7.9 buffer for five compounds: 
EB, DDMB, MAPEC, MAPAC and MMPB. A representative spectro-
photometric titration of EB with calf thymus DNA is shown 
in Figure 3. Scatchard plots derived from these experiments 
are shown in Figures 4-8. The binding parameters are sum-
marized in Table 1. 
The Scatchard plots indicate the existence of two 
distinct processes of unequal strength for the binding of the 
phenanthridinium dyes to DNA. The intrinsic association 
constant calculated for EB (2 x 106 l/mole) is in good agree-
,_ 
ment with values obtained previously under similar conditions 
(Waring, 1965b; Angerer and Moudrianakis, 1972). Moreover, 
the association constants for the primary binding for all 
five compounds studied are in close agreement with each 
other. The diamino compounds, however, tend to exhibit 
somewhat higher association constants. A similar trend is 
also observed for the number of binding sites per DNA ph6s-
phate; again, the diamino compounds appear to have a higher 
number of binding sites than the monoamino derivatives, r 
indicating that the primary amino substituent at position 3 
of the ring may contribute to the overall stabilization of 
the complex. 
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Figure 3. Spectrophotometric titration of EB with 
calf thymus DNA in 0.04 M Tris-HCl, pH 7.9 buffer. Light 
path: 5.0 cm. (EB) = 4 x 10-S t!· (DNA) = 0 (curve A), 
o.z x 10-4 M (curve B), 0.4 x 10- 4 M (curve C), 0.8 x 10-4 M 
(curve D), 13 x 10-4 M (curve E), 3 x 10-4 M (curve F). 
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Figure 4. Scatchard plot for the interaction of EB 
with DNA at room temperature. Buffer: 0.04 ~ Tris-HCl, 
pH 7.9. 
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Figure 5. Scatchard plot for the interaction of 
DDMB with DNA at room temperature. Buffer: 0.04 M Tris-
HCl, pH 7.9. 
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Figure 6. Scatchard plot for the interaction of 
MAPEC with DNA at room temperature. Buffer: 0.04 M 
Tris-HCl, pH 7.9. 
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Figure 7. Scatchard plot for the interaction of 
MAPAC with DNA at room temperature. Buffer: 0.04 M Tris-
HCl, pH 7. 9. 
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Figure 8. Scatchard plot for the interaction of 
MMPB with DNA at room temperature. Buffer: 0.04 M 
Tris-HCl, pH 7.9. 
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T A B L E 1 
Binding parameters for the interaction of certain 
phenanthridinitun compounds with DNA 
Compound K (1/mole) !! -as~. 
Diamino: 
EB 2.0 x 106 0.27 
DDMB 3.8 x 106 0.27 
Monoamino: 
MAPAC 1.3 x 106 0.24 
MAP EC 0.6 x 106 0.24 
MMPB 1.1 x 106 0.24 
Buffer: 0.04 M Tris-HCl, pH 7.9. Temperature: 25°C. 
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1.2. High ionic strength conditions 
In order to determine the extent of electrostatic 
force contribution to the overall binding energy of the 
EB-DNA complex, the binding of this compound to DNA was 
studied in the presence of 5.0 M NaCl. In addition, this 
binding study provided the necessary information for the cal-
culation of the bound dye concentration in subsequent CD 
experiments that were performed under the same conditions 
(Results, Section 2.3). 
The Scatchard plot for the interaction of EB with 
DNA in the presence of 5.0 M NaCl is shown in Figure 9. All 
points fell on a straight line, indicating that, under 
these conditions, secondary binding is eliminated. It is 
also interesting to note the resulting substantial decrease 
in the association constant (2.8 x 105 l/mole in 5.0 M 
buffer as comP,ared with 2.0 x 106 l/mole in 0.04 ~buffer) 
and in the number, n, of binding sites per DNA phosphate 
(0.19 in 5 M buffer as compared to 0.27 in 0.04 M buffer). 
These changes in the bind~ng characteristics of EB 
are not surprising, since, at neutral pH, electrostatic 
forces between the cationic dye and the negatively charged 
phosphates of the helix may comprise a considerable part of 
the forces stabilizing the dye-DNA complex (Gilbert and 
Claverie, 1968). Similar decreases in the association con-
stant in the presence of increased sodium ion concentrations 
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Figure 9. Scatchard plot for the interaction of EB 
with DNA at room temperature. Buffer: 0.04 ~ Tris-HCl, 
5 M NaCl, pH 7.9. 
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have also been reported previously (LePecq and Paoletti, 
1967). 
1.3. Binding in the presence of magnesium 
The binding of four phenanthridinium compounds (EB, 
DEMB, MAPAC and MAPEC) was also studied in the presence of 
magnesium ions, both at room temperature and at 37°C. These 
experiments provided binding constant values which are needed 
for the estimation of the DNA-bound drug in conditions under 
which the subsequent enzymic studies were performed (Results, 
Sections 5 and 6). 
The change in the absorption spectrum of EB upon 
addition of increasing amounts of calf thymus DNA is shown 
in Figures 10 and 11. The buffer used in these experiments 
was 0.04 M potassium phosphate, 0.008 M MgC12 , pH 7.0. 
Similar absorption spectra were also recorded for the other 
three phenanthridinium compounds. The Scatchard plots for 
these experiments are shown in Figures 12-15 and the binding 
parameters are summarized in Table 2. 
Examination of the Scatchard plots shows that all the 
experimental points fall on a straight line, indicating that, 
under these conditions, secondary binding is eliminated. 
This is an expected finding in view of a previous report 
(Waring, 1965b) that no secondary binding is observed in the 
interaction of EB with DNA in the presence of 0.004 M MgClz· 
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Figure 10. Spectrophotometric titration of EB with 
calf thymus DNA in 0.04 M potassium phosphate, 0.008 M 
MgC12 , pH 7.0. Light path: 10.0 cm. Temperature: 25°c. 
(EB) = 2 x io- 5 M· (DNA) = O (curve A), 0.5 x io-4 M 
(curve B), 0.7 x io-4 M (curve C), 1.1 x io- 4 M (curve D), 
2.3 x io-4 M (curve E), 9.2 x io- 4 M (curve F). 
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Figure 11. Spectrophotometric titration of EB with 
calf thymus DNA in 0.04 M potassium phosphate, 0.008 M 
MgC1 2 , pH 7.0. Light path: 10.0 cm. Temperature: 37°C. 
(EB) = 2 x 10-5 M. (DNA) = 0 (curve A), 0.7 x 10- 4 (curve 
B), 1.2 x 10- 4 M (curve C), 1.7 x 10-4 M (curve D), 
15 x 10- 4 M (curve E). 
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Figure 12. Scatchard plot for the interaction of 
EB with DNA at 25°C (0) and at 37°c (t). Buffer: 0.04 M 
potassium phosphate, 0.008 M MgC12 , pH 7.0. 
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Figure 13. Scatchard plot for the interaction of 
DEMB with DNA at 25°C (0) and at 37°C (I). Buffer: 0.04 M 
potassium phosphate, 0.008 M MgC12 , pH 7.0. 
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Figure 14. Scatchard plot for the interaction of 
MAPEC with DNA at 25°c (0) and at 37°c (e). Buffer: 0.04 M 
potassium phosphate, 0.008 M MgC12 , pH 7.0. 
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Figure 15. Scatchard plot for the interaction of 
MAPAC with DNA at 25°c (0) and at 37°c (t). Buffer: 0.04 M 
potassium phosphate, 0.008 ~ MgC12 , pH 7.0. 
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TA BL E 2 
Binding parameters for the interaction of certain 
phenanthridinium comi:x:>unds with DNA 
25°C 37°c 
Compound K (1/mole) 
-ass. K (1/mole) -ass. 
Diamino: 
EB 2.2 x 105 0 .20 1.6 x 105 0.20 
DDMB 1.9 x 105 0.23 
DEMB 2.2 x 105 0.20 1.0 x 105 0.20 
Monoamino: 
MA PAC 1.7 x 105 0.17 1.1 x 105 0.17 
MAPEC 2.0 x 105 0.16 1.2 x 105 0 .16 
Buffer: 0.04 M potassium phosphate, 8 m~ MgC12 , pH 7.0. 
l .. 
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It is also evident that, under these conditions, as the case 
was with measurements made in 0.04 M Tris buffer (Results, 
Section 1.1), the association constants for the diamino 
compounds are slightly higher than those of the monoamino 
derivatives. These differences, however, are more pronou~­
ced at 25°C than at 37°C. The elimina~ion of the differehces 
between the binding constants of the mono- and diamino-
derivatives at higher temperature suggests that any advan-
tage, in terms of binding energy, conferred upon the diamino 
compounds by the primary amino group at position c3 , is 
almost totally eliminated by a 12-degree increase in tern-
perature. 
It is also interesting to note that an increase of 
the temperature from 25°C to 37°C does not affect apprecia-
bly, if at all, the number, n, of binding sites per DNA 
phosphate, although at the higher temperature the association 
constant decreases by a factor of, approximately, two 
(Table 2). A similar observation was previously reported 
in a fluorometric study of the binding of EB to DNA (LePecq 
and Paoletti, 1967). 
In summary, the binding data presented above are in 
agreement with previous studies indicating that the inter-
action of phenanthridinium compounds with DNA consists of 
two binding processes: the primary binding, which is the 
stronger of the two and which predominates at low added 
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drug/nucleotide ratios, and the secondary binding, which 
is observed at high values of these ratios. 
The secondary binding is extremely sensitive to 
changes in ionic strength and it is eliminated in the pres·en-
ce of 0.008 ~ MgC12 (Figures 12 - 15). In fact, it has been 
reported that no secondary binding could be detected in the 
interaction of EB with DNA in the presence of as little as 
0.004 ~ MgC12 (Waring, 1965b). The increased sensitivity 
of this type of binding process to salt concentration indi-
cates that secondary binding relies mainly, if not exclusive-
ly, on electrostatic forces. This observation further 
supports the idea, initially advanced by LePecq and Paoletti 
(LePecq and Paoletti, 1967) that electrostatic forces are 
primarily responsible for the binding of EB .to the secondary 
sites of DNA. These electrostatic forces·are exerted between 
the negatively charged phosphate residues on the outside 'of 
the helix and the cationic dye molecule, since, at neutral 
pH, the ethidiurn molecule carries a single positive charge 
due to the quaternized nitrogen at position 5 of the ring. 
This mechanism of binding may very well be true also for the 
other phenanthridiniurn derivatives studied. 
The primary binding is also influenced by ionic 
strength, although much less extensively than the secondary 
binding. This is indicated in Tables 1 and 2. At relatively 
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low salt concentration (less than 0.1~), binding parameters 
were found to decrease with increasing salt concentration. 
However, at higher salt concentrations, the binding appears 
independent of ionic strength (Figures 9 and 12). Similar 
findings were reported previously for the EB-DNA interaction 
(LePecq et al., 1964). It was found in that instance that 
the affinity of EB for DNA becomes independent of the ionic 
strength above 0.2 M for divalent ions and above approximate-
ly 1 M for monovalent ions. These observations indicate 
that the stabilizing forces of the phenanthridiniurn-DNA 
complex consist mainly of two components, only one of which 
is sensitive to salt concentration. 
This conclusion is consistent with the model of 
binding, initially proposed by Fuller and Waring (Fuller and 
Waring, 1964) and subsequently supported by the work of LePecq 
and Paoletti (LePecq and Paoletti, 1967). The model postu-
lates that the DNA-EB complex is stabilized mainly by 
hydrophobic forces between the DNA base pairs and the phenan-
thridiniurn ring system. These forces are not expected to be 
affected by increased ionic strength and should be mainly, if 
not exclusively, responsible for the binding observed at 
high salt concentrations. 
Additional stabilization of the complex is provided 
by hydrogen bonds formed between the primary amino groups at 
positions 3 and 8 of the ring and the negatively charged 
phosphate residues on both polynucleotide strands. These 
f 
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interactions, in contrast wtth the hydrophobic forces men-
tioned in the previous paragraph, are sensitive to the salt 
concentration of the medium. Therefore, it appears that the 
decrease in binding strength, observed with increasing salt 
concentrations, is due to the elimination of these hydrogen 
bonds. 
2. CIRCULAR DICHROISM STUDIES 
The method of circular dichroism is especially well 
suited for the study of the conformation of the phenanthri-
dinium-DNA complexes. CD is extremely sensitive to small 
changes in the conformation of the polymer under study; 
differences, therefore, in the conformation of the dye-DNA 
complexes may be conveniently detected. 
In addition, evidence about the conformation of a 
dye-DNA complex may be obtained by relating the experimen-
tally observed CD spectrum to that predicted by theoretical 
models. 
The circular dichroism of the phenanthridinium-DNA 
complexes was studied in the wavelength region between 300 
and 600 nm. Neither of the components alone exhibits any 
optical activity in this region. Several bands appear, 
however, in the CD spectrum when these dyes are complexed 
with DNA. 
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2.1. Diamino compounds 
The CD spectra of the DNA complexes of two diamino 
phenanthridinium compounds (EB and DDMB) are shown in 
Figures 16 and 17 (note that the ellipticity scale must be 
multiplied by 0.1 for wavelengths above 350 nm). The spectra 
in each Figure are obtained from complexes containing in-
creasing added dye/nucleotide ratios. The striking similari-
ties between the two families of spectra should be noted. 
In both cases there are three main regions of optical 
activity: one major positive band with a maximum close to 
310 nm and a shoulder at, approximately, 340 nm; a negative 
band with a maximum around 370 nm; and a weaker, wide 
negative band with a maximum close to 500 nm. 
In addition, a small negative band, centered near 
295 nm, may be observed in the spectrum of the EB-DNA com-
plex. This band is clearly distinguishable only at the high 
added dye/nucleotide samples, i.e. those containing low DNA 
concentrations. It is likely, therefore, that this band is 
not observed in lower EB/nucleotide ratios merely because 
it is masked by the much stronger positive band at 280 nm 
of the DNA spectrum. 
The significance of these bands, in respect to their 
possible assymmetric source(s), will be examined in subse-
quent sections by studying the dependence of molar ellipti~ 
city on the bound dye/nucleotide ratio. 
r 
' 
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Figure 16. CD spectra of the EB-DNA complex at three 
(indicated) added EB/nucleotide ratios. Ellipticity values 
for wavelength above 350 nm are multiplied by a factor of 
10. 
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Figure 17. CD spectra of the DDMB-DNA complex at 
three (indicated) added DDMB/nucleotide ratios. Ellipticity 
values for wavelengths above 350 nm are multiplied by a 
factor of 10. Buffer: 0.04 ~ Tris-HCl, pH 7.9. 
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2.1.1. The circular dichroism at 500 nm 
Examination of Figures 16 and 17 indicates that the 
molar ellipticity of the diaminophenanthridinium-DNA comple-
xes at 500 nm is independent of complex concentration. This 
point is more clearly illustrated in Figure 18, in which the 
£1 - tr at 500 nm of the EB-DNA complex is plotted as a 
function of £· 
Allowing for experimental error, which, in this case, 
can be substantial because of the very low optical activity 
of the drug-DNA complex at this wavelength, a horizontal 
line can be drawn through.all points. The molar ellipticity 
of the EB-DNA complex at 500 nm is approximately -0.4, 
irrespective of the concentration of the complex. 
A similar behavior is exhibited by the DDMB-DNA 
complex. The value of E1 - Er at 500 nm is, again, approxi-
mately -0.4 (Figure 19). 
This independence of molar ellipticity of the com-
plex on the concentration of DNA-bound dye is, of course, 
expected as a consequence of Beer's law. Indeed, since 
E1 - Er is derived by, essentially, normalizing the observed 
ellipticity to the concentration of the complex (Methods, 
Section 4), it expresses the optical activity per mole of 
this complex, a parameter which should be independent of 
complex concentration. 
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Figure 18. Dependence of molar ellipticity of the 
EB-DNA complex at the band maximum near 500 nm on r. 
Buffer: 0.04 M Tris-HCl, pH 7.9 . 
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Figure 19. Dependence of molar ellipticity of the 
DDMB-DNA complex at the band maximum near 500 nm on r. 
Buffer: 0.04 ~ Tris-HCl, pH 7.9. 
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2.1.2. The circular dichroism at 310 run 
As already indicated in Figures 16 and 17, quite 
different behavior is displayed by the molar ~llipticity at 
310 run. The dependence of molar ellipticity of the EB-DNA 
complex at that wavelength on £ is depicted in Figure 20. 
It is evident from this Figure that, in contrast with the 
behavior of the molar ellipticity at 500 run and in apparent 
contradiction of Beer's law, the molar ellipticity at 310 
run is not independent of complex concentration. In fact, 
E1 - Er at 310 run increases with ~ reaching an apparent 
maximum of approximately 25 at an£ value between 0.30 and 
0.35, a ratio which corresponds to the saturation of the 
DNA-binding sites by EB. 
In the case of the DDMB-DNA complex., a very similar 
dependence of E1 - Er on r is observed, as shown in Figure 21; 
indeed, the molar ellipticity of the DDMB-DNA complex at 
the band maximum near 310 run increases with increasing £• 
The dependence appears sigmoid in shape and the molar ellip-
ticity value reaches an apparent maximum of 20 for an £ of 
approximately 0.30. 
This variation of the molar ellipticity at 310 run 
of the DNA-diaminophenanthridinium complexes suggests that 
the mere fact that a dye molecule is bound to DNA is not a 
sufficient requirement for optical activity at this wavelength. 
Rather, it appears that ellipticity at the band maximum 
~ 
• 
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Figure 20. Dependence of molar ellipticity of the 
EB-DNA complex at the band maximum near 310 nm on r. 
Buffer: 0.04 ~ Tris-HCl, pH 7.9. 
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Figure 21. Dependence of molar ellipticity of the 
DDMB-DNA complex at the band maximum near 310 nm on £· 
Buffer: 0.04 M Tris-HCl, pH 7.9. 
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near 310 nm depends on the "density" of the bound molecule 
population within a given segment of the nucleic acid, indi-
cating that this ellipticity results from interactions, 
either direct of indirect, between dye molecules bound at 
neighboring sites on the DNA. 
2.2. Monoamino compounds 
Compared with the CD spectra of the diaminophenan-
thridinium-DNA complexes just described, the spectra of the 
complexes of the monoamino substituted drugs with DNA show 
considerable differences both in terms of overall shape as 
well as ellipticity values. Three monoamino compounds were 
studied: MAPEC, MAPAC and MMPB. The CD spectra of the 
complexes of these compounds with DNA at three different 
added drug/nucleotide ratios are shown in Figures 22-24 
(note that in this case, in contrast with the diamino dyes-
DNA CD spectra, the ellipticity scale above 350 nm is not 
multiplied by 0.1). 
Certain similarities, both qualitative and quantita-
tive, may be noted between the spectra of the three families. 
Specifically, two main areas of optical activity are dis-
tinguished in each spectrum: one comprised of a negative 
band with a maximum at, approximately, 470 nm, and an area 
of positive optical activity which extends in the wavelength 
region between 300 and 360 nm and which consists of at least 
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Figure 22. CD spectra of the MAPEC-DNA complex at 
three (indicated) added MAPEC/nucleotide ratios. Buffer: 
0.04 M Tris-HCl, pH 7.9. 
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Figure 23. CD spectra of the MAPAC-DNA complex at 
three (indicated) added MAPAC/nucleotide ratios. Buffer: 
0.04 M Tris-HCl, pH 7.9. 
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Figure 24. CD spectra of the MMPB-DNA complex at 
three (indicated) added MMPB/nucleotide ratios. Buffer: 
0.04 M Tris-HCl, pH 7.9. 
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three individual bands. A small, negative band centered 
around 390 nm may also be present. This latter band is not 
observed in the spectrum of the MMPB-DNA complex. 
In quantitative terms, the spectra presented in 
Figures 22 - 24 indicate that the complexes of monoamino 
dyes with DNA exhibit substantially lower molar elliptici-
ties at the short wavelength region (300 - 350 nm) as com-
pared to the corresponding complexes of the diamino drugs. 
Exactly the opposite is observed at the long (470 - 500 nm) 
wavelength region, where the complexes of the monoamino 
drugs have ellipticity values that are approximately five 
times higher than those observed with the diamino compoupds. 
These differences between the two classes of the CD 
spectra examined indicate that the conformat~on of the 
DNA-monoamino phenanthridinium complexes ts quite distinct 
from that of the complexes formed from diamino derivatives. 
This observation also suggests that, in general, the number 
of primary amino substituents on the phenanthridinium ring 
may have a significant effect on the conformation of the · 
dye-DNA complex. 
Ihe conf orrnation of the monoamino phenanthridinium-
DNA complex was studied in more detail by examination of 
the dependence of the molar ellipticity at the band maximum 
near 315 nm and 470 nm on r. 
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2.2.1. The circular dichroism at 470 nm 
As indicated in Figures 22 - 24, the negative band 
with the 470 nm extremum displays a behavior reminiscent of 
that of the 500 nm maximum of the diamino compounds, i.e. 
molar ellipticity at this wavelength appears independent of 
complex concentration. The dependence·of molar CD at that 
wavelength on complex concentration is shown in Figures 
25 - 27. Although the absolute magnitudes of molar ellip-
ticities of -2.4 to -3.0 are higher than those noted with 
the diamino compounds, ellipticity values remain, as the 
case is with diamino derivatives, constant, irrespective of 
the concentration of the drug-DNA complex. These findings 
indicate that the nature of the interactions responsible 
for the long wavelength dichroic band are probably not 
affected significantly by the lack of the 3-amino substituent 
from the intercalated molecule. 
2.2.2. The circular dichroism at the maximum near 315 nm 
In contrast with the behavior of the molar CD at the 
370 nm extremum, the molar CD at the short wavelength maxi-
mum is not independent of the concentration of the complex. 
The dependence of the molar ellipticity of the drug-DNA 
complex at the band maximum near 315 nm on the concentrat-
ion of the complex is shown in Figures 28 - 30. 
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Figure 25. Dependence of molar ellipticity of the 
MAPEC-DNA complex at the band maximum near 470 nm on r. 
Buffer: 0.04 M Tris-HCl, pH 7.9. 
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Figure 26. Dependence of molar ellipticity of the 
MAPAC-DNA complex at the band maximum near 470 nm on r. 
Buffer: 0.04 M Tris-HCl, pH 7.9. 
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Figure 27. Dependence of molar ellipticity of the 
MMPB-DNA complex at the band maximum near 470 nm on r. 
Buffer: 0.04 M Tris-HCl, pH 7.9. 
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Figure 28. Dependence of molar ellipticity of the 
MAPEC-DNA complex at the band maximum near 315 nm on £• 
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Figure 29. Dependence of molar ellipticity of the 
MA.PAC-DNA complex at the band maximum near 315 nm on £• 
Buffer: 0.04 M Tris-HCl, pH 7.9. 
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Figure 30. Dependence of molar ellipticity of the 
MMPB-DNA complex at the band maximum near 315 nm on r. 
Buffer: 0.04 tl Tris-HCl, pH 7.9. 
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Although the molar ellipticity increases somewhat 
with complex concentration, this increase is much less 
pronounced than the one observed with the diamino compounds 
and the final E1 - tr values are less than one-third of 
those obtained with the diamino compounds for the same r 
values. In addition, this modest increase in molar ellip-
ticity is accompanied by significant changes in the shape 
of the spectrum itself, as indicated by the sign-reversal 
of the molar ellipticity near 315 nm. Indeed, Figures 
28 - 30 indicate that, at low bound dye/nucleotide ratios, 
the ellipticity at 315 nm has negative values, although 
it becomes positive at higher£ values. This ellipticity 
sign change occurs at an£ of approximately 0.10. 
A similar sign change in ellipticity has been 
reported for the interactio~ of proflavine with DNA. It 
was interpreted as the result of mutual cancelling or re-
inforcement between three circular dichroism bands (Li and 
Crothers, 1969). In the case of monoamino phenanthridinium 
compounds, at least three distinct bands may be observed 
in the 300 to 350 nm region of the CD spectrum of their 
complexes with DNA. Therefore, the sign reversal for the 
ellipticity at 315 nm mentioned above may reflect a mutually 
cancelling relationship between some or all of these bands. 
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2.3. Circular dichroism of the EB-DNA complex at high ionic 
strength 
Under the conditions the present CD studies were 
performed (0.04 M Tris buffer, room temperature), two types 
of binding are observed: primary binding, involving inter-
calation of the drug molecules between,successive base 
pairs, and secondary binding, representing drug molecules 
bound electrostatically to the outside of the helix. Thus 
the question arises whether the observed ellipticity is the 
result of only one type of binding or both. The study of 
the circular dichroism of the EB-DNA complex at high ionic 
strength (5.0 M NaCl) provides information helpful in 
answering this question. 
In addition, high ionic strength conditions provide 
a means of studying in more detail the negative CD band 
observed near 295 nm in the EB-DNA spectrum. As mentioned 
earlier (Results, Section 2.1) the low ellipticity values 
associated with this maximum were attributed to an overlap 
of this band with the positive band of the DNA-CD spectrum. 
It was decided, therefore, to examine the behavior of the 
CD spectrum of the EB-DNA complex at that wavelength in 
conditions under which the positive CD contribution from 
nucleic acid is reduced. Such conditions exist in high salt 
concentrations; it has been reported that, in 6.0 M LiCl, 
the ellipticity of DNA in the 260 - 290 nm region is 
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substantially reduced, with an especially pronounced reduc-
tion above 290 nm (Studdert et al., 1972). We observed 
similar, although less drastic, changes in the CD of DNA in 
5.0 M NaCl. 
The general features of the CD of the EB-DNA complex 
are not substantially altered in 5.0 M'NaCl solution 
(Figure 31). Apart from an increase in the ellipticity of 
the 375 nm band, both the ellipticities and the maxima of 
the other bands located at wavelengths higher than 310 nm 
remain unchanged. In fact, the results listed in Table 3 
indicate that ellipticities at 310 nm as well as 500 nm 
remain remarkably constant for salt concentrations which 
vary between 0.04 and 5.0 M· Furthermore, examination of 
Figure 32 reveals that the dependence of the ellipticities 
near 310 nm on bound EB to DNA ratios at 5.0 M NaCl exhibits 
a close similarity to the results obtained in 0.04 M buffer. 
The only apparent qualitative difference between the spectra 
at 0.04 M buffer and 5.0 M NaCl is that in the latter the 
negative CD band located near 295 nm is present for all 
ethidium bromide to DNA ratios examined, while at the lower 
ionic strength this band is present only for high EB to DNA 
ratios. 
These results suggest that contributions from nega-
tive CD in the vicinity of this band may in fact be present. 
r ;, 
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Figure 31. CD spectrum of the EB-DNA complex at an 
added EB/nucleotide ratio of 0.1. Buffer: 0.04 M Tris-HCl, 
5.0 M NaCl, pH 7.9. Ellipticity values for wavelength above 
360 run are multiplied by a factor of 10. 
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T A B L E 3 
Circular dichroism of the EB - DNA complex at 
various salt concentrations 
NaCl, (M) El-Er near 310 nm E 1-Er near 500 nm 
5.2 -0.53 
0.12 6.1 -0.41 
0.20 6.0 . -0. 46 
0.50 6.1 -0.48 
0.60 5.4 -0.45 
0.75 5.5 -0.41 
1.0 6.0 -0.50 
.5. 0 5.4 -0.46 
Measurements were carried out for samples of added 
EB/nucleotide ratios between 0.085 and 0.28, with r values 
ranging between 0.085 and 0.14. El-Er values for the maxi-
mum near 310 nm are reported for an£ of 0.085 and were 
estimated from plots of El-Er versus£· 
r 
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Figure 32. Dependence of molar ellipticity of the 
EB-DNA complex at the band maximum near 310 nm. Buffer: 
0.04 M Tris-HCl, 5.0 M NaCl, pH 7.9. 
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for low EB to DNA ratios as well but a definite band near 
295 nm can be distinguished only at higher ionic strengths 
or at higher ratios .. 
The increase in the CD and the shift in the apparent 
maxi.mum of this band from 296 to 292 nm noted with increa~ing 
£ at constant concentration of EB and ~hanging DNA concentra-
tions (Table 4) may simply be interpreted as the result of 
two distinct trends: the increase in the negative CD origi-
nating from transitions characteristic of the interaction 
between DNA and EB and the increase in the overlap between 
the CD originating from this interaction with the positive 
CD of DNA present at wavelengths below 300 nm. This overlap 
would tend to produce the shift in t he apparent maximum of 
the 295 nm band and would limit ellipticities even at the 
higher EB to DNA ratios. However, substantially higher 
ellipticities near 295 nm are noted in 5.0 ~NaCl (Figure 
33). This increase is, of course, consistent with the ex-
pected decrease in the contribution of the positive CD of 
DNA below 300 nm. 
The variations in the ellipticities of the complex 
near 295 nm with r noted both at 0.04 M buffer and at 5.0 M 
NaCl, when the CD is obtained at constant DNA concentration 
(Figure 33, Table 5) deserves some comment. The only appa-
rent explanation for these results is that the negative CD 
r 
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T A B L E 4 
Dependence of molar ellipticity of the EB-DNA complex 
near 295 run on £ 
Added 
EB/DNA ratio 
0.15 
0.25 
1.00 
0.15 
0.21 
0.24 
A max(nm) 
296 
295 
292 
Buffer: 0.04 M Tris-HCl, pH 7.9. 
/ 
E: 1 -e: at A r max 
-0.7 
-1.7 
-2.0 
r 
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Figure 33. The circular dichroism of EB-DNA complex 
in 0.04 ~ Tris-HCl, 5.0 ~.NaCl, pH 7.9 buffer at various r 
values. Upper curve, £ = 0.086; middle curve, r = 0.162; 
lower curve, £ = 0.180. 
2CO 3oo 3IO 31/J 
.A,nm 
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T A B L E 5 
Dependence of molar ellipticitiy of the EB-DNA com-
plex near 295 nm on r 
Added 
'A (run) E -f. at A EB/DNA ratio £ max 1 r max 
0.10 0.085 297 -3.2 
0.20 0.133 296 -3.6 
0.40 0.162 295 -5.4 
0.50 0.164 295 -5.7 
0.65 0.164 295 -6.3 
0.80 0.165 294 -6.4 
1.00 0.180 294 -7.2 
Buffer: 0.04 tl Tris-HCl, 5.0 M NaCl, pH 7.9. 
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near 295 run exhibits an intrinsic dependence on the EB/DNA 
ratios, increasing as the ratio increases. The behavior 
of the 295 run band appears therefore to be similar to that 
noted for the positive CD band near 310 run and distinct from 
that of the band centered at 500 run. This indicates that 
the 295- and the 310-run bands may have similar origin. In 
fact, the relationship between these two bands in terms of 
both their neighboring positions and the dependence of their 
ellipticities on £ strongly suggests that these bands are 
manifestations of the positive and the negative CD components 
of the same conservative transition (Tinoco, 1964). 
The generally lower ellipticities noted for the 
negative component and the somewhat asymetric shape of the 
doublet are, of course, consistent with the.overlap between 
this band and the CD of the DNA below 300. run. 
3. FLUORESCENCE STUDIES 
Additional information regarding the conformation of 
the DNA-phenanthridinium complex may be obtained from the 
study of the effect of DNA binding on the fluorescence 
properties of these compounds. It is known that the fluo-
rescence intensity of.EB increases substantially upon 
binding to double-stranded DNA (LePecq et al., 1964), Fluo-
rescence is a molecular property, the expression of which 
depends on such environmental factors as solvent pH, 
r 
J 
J 
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viscosity, polarity etc., as well as the specific geometric 
orientation of the fluorescing molecules. Since the confor-
mation of the DNA-phenanthridiniurn complex is influenced by 
the number of primary amino substituents of the intercala-
ted molecule, as indicated by the CD studies presented above, 
it was thought interesting to examine the effect of these 
substituents on the fluorescence enhancement of the phenan-
thridiniurn compounds upon binding to DNA. 
The effect of DNA on the fluorescence of EB is 
illustrated in Figure 34. The fluorescence increase in the 
presence of DNA is very similar to that reported previous-
ly (LePecq et al., 1964). The increase in fluorescence as a 
function of the bound dye/nucleotide ratio is shown in 
Figure 35. In this Figure, the net fluorescence per mole of 
bound drug, calculated as described in Section 5 (Methods), 
is plotted versus £• 
As shown in this Figure, the net fluorescence per 
mole of bound drug increases approximately 30-fold when all 
the drug is intercalated to DNA (low£ values). The fluo-
rescence values are independent of the concentration of the 
complex for low£ values, but later decrease as £increases. 
This apparent decrease is probably due to the fact that the 
total concentration of bound ethidiurn is used in the cal-
culation of fluorescence. However, a proportion of bound 
EB represents molecules which are attached via electrostatic 
r . ~· 87 
Figure 34. Fluorescence emission spectrum of free 
EB (curve A) and EB in the presence of 8.6 x 10- 4 M calf 
thymus DNA (curve B). (EB) = 4.6 x 10-5 Min both samples. 
Excitation wavelength: 530 nm. The 530 nm band represents 
scattered excitation light. Ordinate: Fluorescence in-
tensity in arbitrary units. Buffer: 0.04 M Tris-HCl, 
pH 7.9. 
-
·-fl) 
c 
G) 
-c 
G) 
() 
c 
G) 
() 
fl) 
G) 
.. 
0 
:I 
-IL 
B 
500 600 
l, nm 
EB 
700 
88 
Figure 35. Dependence of molar fluorescence of the 
EB-DNA complex on £· Excitation wavelength: 530 nm. 
Emission wavelength: 590 nm. Buffer: 0.04 ~ Tris-HCl, 
pH 7.9. 
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interactions on the outside of the helix and which have a 
fluorescence efficiency that is very similar to that of the 
free drug (LePecq and Paoletti, 1967). Since the propor-
tion of these bound molecules increases with increasing r, 
it is reasonable to expect a decrease in the average fluo-
rescence intensity per mole of bound drug. 
Similar results were obtained with the DDMB-DNA com-
plex (Figure 36). Again, an increase in fluorescence inten-
sity of approximately 20-fold is observed upon binding of 
the drug to the nucleic acid. 
A distinctly different picture, however, emerges from 
the interaction of monoamino compounds with DNA. A represen-
tative emission spectrum of MAPAC in the presence and absence 
of DNA is shown in Figure 37. As indicated in this Figure, 
the fluorescence of MAPAC does not increase very much upon 
binding to DNA. 
The dependence of the fluorescence of MAPAC and MAPEC 
on the bound dye/nucleotide ratio is shown in Figures 38 and 
39. Because of the very low fluorescence intensity of these 
compounds, the experimental error of the measurements presen-
ted in Figures 38 and 39 may be considerable. It is evi-
dent, nevertheless, that a fluorescence enhancement, similar 
to that observed in the case of the diamino derivatives, 
does not take place. 
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Figure 36. Dependence of molar fluorescence of the 
DDMB-DNA complex on r. Excitation wavelength: 517 nm. 
Emission wavelength: 580 nm. Buffer: 0.04 M Tris-HCl, 
pH 7.9. 
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Figure 37. Fluorescence emission spectrum of free 
MAPAC (curve A) and MAPAC in the presence of 8.6 x 10-4 M 
calf thymus DNA (curve B). (MAPAC) = 3.6 x 10- 5 ~in both 
cases. Excitation wavelength: 470 nm. Ordinate: Fluo-
rescence intensity in arbitrary units. Buffer: 0.04 M 
Tris-HCl, pH 7.9. 
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Figure 38. Dependence of molar fluorescence of the 
MAPEC-DNA complex on £· Excitation wavelength: 470 nm. 
Emission wavelength: 555 nm. Buffer: 0.04 M Tris-HCl, 
pH 7.9. 
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Figure 39. Dependence of molar fluorescence of the 
JvIAPAC-DNA complex on r. Excitation wavelength: 470 nm. 
Emission wavelength: 560 nm. Buffer: 0.04 M Tris-HCl, 
pH 7.9. 
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In the case of another monoamino phenanthridinium 
drug, MMPB (Figure 40), fluorescence per mole of DNA-bound 
drug does increase, approximately 5-fold, upon binding of 
the drug to DNA. This, however, is a relatively small in-
crease, compared with the 20- to 30-fold increase exhibited 
by the diamino compounds, and, in any case, the resulting 
fluorescence intensity is less than 1/20 of the correspon-
ding intensity observed with the diamino compounds. 
It appears, therefore, that the effect of DNA bin-
ding on the fluorescence intensity of the phenanthridinium 
drugs is quite distinct for the monoamino derivatives than 
it is for the diamino compounds. This differential effect 
may be another reflection of the conformational differences, 
already suggested by the CD experiments, between the two 
classes of complexes. These conformational differences are 
expected to influence the interactions of the intercalated 
dyes with their molecular environment and, consequently, may 
be responsible for the observed differences in fluorescence 
intensity. 
4. TEMPERATURE - OPTICAL DENSITY PROFILES 
Several intercalating compounds, including EB, have 
been shown to increase the melting temperature of DNA 
(Kleinwachter and Koudelka, 1964; Gersch and Jordan, 1965; 
Waring, 1974). However, no systematic study has been 
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Figure 40. Dependence of molar fluorescence of the 
MMPB-DNA complex on £• Excitation wavelength: 475 nm. 
Emission wavelength: 560 nm. Buffer: 0.04 M Tris-HCl, 
pH 7.9. 
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undertaken to determine the relationship, if any, between 
the chemical structure of the intercalating molecule, as 
expressed in the conformation of the resulting complex, and 
the thermal stability of the complex. Such information is 
useful in understanding the nature of forces involved in 
stabilizing the dye-DNA complex, as well as evaluating the 
effect of the phenanthridinium dyes on the activity of en-
zymes, such as DNA polymerase, the action of which requires 
that DNA be in the single-stranded form. 
The effect of the various substituents of the phenan-
thridinium ring on the stability of the DNA-phenanthridinium 
complexes was studied by means of the temperature-optical 
~ density profiles (Tm profiles) of these complexes. The 
I 
~ i phenanthridinium compounds used in this study were: EB, DEMB, 
DDMB, MAPEC, MAPAC and MMPB. The temperature-optical density 
profiles at 260 nm were obtained as described in Section· 6 
(Methods), using samples with an added dye to nucleotide 
ratio of 0.10. 
The melting profiles of DNA alone and of DNA com-
plexed with each of the above phenanthridinium compounds are 
illustrated in Figures 41-47 and the results are summarized 
in Table 6. The melting profiles are plotted as normalized 
(or total) hyperchromicity versus temperature. 
The initial gradual increase in absorbance, observed 
for all drug-DNA complexes before the onset of the melting 
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Figure 41. Temperature-optical density profile at 
260 nm of calf thymus DNA. (DNA)= 1.5 x 10- 4 M· Heating 
rate: 3°C/min. Buffer: 0.04 M Tris-HCl, pH 7.9. 
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Figure 42. Temperature-optical density profile at 
260 nm of the MAPEC-DNA complex. (MAPEC) = 1.5 x 10-5 M. 
(DNA) = 1.5 x io- 4 M· Heating rate: 3°C/min. Buffer: 
0.04 M Tris-HCl, pH 7.9. 
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Figure 43. Temperature-optical density profile at 
260 nm of the MAPAC-DNA complex. (MAPAC) = 1.5 x 10-5 M. 
(DNA)= 1.5 x 10- 4 M· Heating rate: 3°C/min. Buffer: 
0.04 M Tris-HCl, pH 7.9. 
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Figure 44. Temperature-optical density profile at 
260 nm of the MMPB-DNA complex. (MMPB) = 1.5 x 10-5 M. 
(DNA)= 1.5 x 10- 4 M. Heating rate: 3°C/min. Buffer: 
0.04 M Tris-HCl, pH 7.9. 
100 
~ 80 ~ 
-() 
·-E 60 
0 
.. 
.t:. 
() 
.. 40 Q) 
Q. 
>-
:c 
20 
0 
20 40 
MMPB 
60 
0 Temperature, C 
80 100 
10'1 
Figure 45. Temperature-optical density profile at 
260 ( ) 0 -5 nm of the EB-DNA complex. EB = 1.5 x 1 M· 
(DNA)= 1.5 x 10- 4 M. Heating rate: 3°C/min. Buffer: 
0.04 M Tris-HCl, pH 7.9. 
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Figure 46. Temperature-optical density profile at 
260 nm of the DEMB-DNA complex. (DEMB) = 1.5 x 10-5 M· 
(DNA)= 1.5 x 10- 4 M. Heating rate: 3°C/min. Buffer: 
0.04 M Tris-HCl, pH 7.9. 
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Figure 47. Temperature-optical density profile at 
260 nm of the DDMB-DNA complex. (DDMB) = 1.5 x 10-5 M. 
(DNA)= 1.5 x io-4 M· Heating rate: 3°C/min. Buffer: 
0.04 M Tris-HCl, pH 7.9. 
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TABLE 6 
The effect of certain phenanthridiniurn compounds on 
the thermal stability of DNA 
Compound Tm (°C) AT30-1o<Oc) 
None 76. 5 5.5 
Diamino: 
EB 83.2 7.0 
DEMB 83.8 7.0 
DDMB 85.5 4.5 
Monoamino: 
MAPEC 84.5 7.5 
MAP AC 82.8 7.0 
MMPB 82.8 7.0 
Buffer: 0.04 M Tris-HCl, pH 7.9. Light path: 1.0 cm. 
Heating rate: 3°C/min. (DNA) = 1.5 x l0-4M. 
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transition, is probably due to the decrease in drug binding 
with increasing temperature (Results, Section 1.3). Since 
the binding of the dye to DNA is accompanied by a hypo-
chromic effect, the release of bound drug would be expected 
to result in an increase in absorbance. 
The effects of the phenanthridinium derivatives on 
the melting of DNA may be summarized as follows: 
A. The phenanthridinium compounds tested increase 
the thermal stability of the double-helical form of the DNA. 
Similar observations have been made previously for a number 
of intercalating agents, including EB (Kleinwachter and 
Koudelka, 1964; Gersch and Jordan, 1965; LePecq and Paoletti, 
1967). 
B. All derivatives tested, whether ,mono- or diamino, 
increase the melting temperature of DNA to approximately the 
same extent, namely from 76.5°c to an average of 83.8°C. It 
has been reported that in the case of EB as well as of other 
intercalating compounds, such as acridines, the Tm is very 
sensitive to the added drug to nucleotide ratio at low values 
of this ratio (Kleinwachter and Koudelka, 1964; Gersch and 
Jordan, 1965; Waring, 1974). Therefore, the small differen-
ces observed in the presence of different phenanthridinium 
derivatives may simply be due to potential experimental 
error in determining the concentration of the drug. 
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C. The width of the melting transition, as measured 
by .b.T30 _70 , increases from 5.5°C, in the case of DNA, to 
approximately 7.0°c for the dye-DNA complexes. 
The significance of these findings, in terms of the 
stability and conformation of the phenanthridiniurn-DNA corn-
plexes, is examined in subsequent chapters. 
5. INHIBITION OF DEOXYRIBONUCLEASE 
A study of the inhibition of DNase by phenanthridi-
niurn compounds was undertaken in order to examine further 
the effect of the chemical structure of the intercalated drug 
on the conformation of the drug-DNA complex. Enzymes, in 
general, and DNase I, in particular, have specific confor-
rnational requirements for their substrates. Therefore, any 
factor affecting substrate conf orrnation would also be expec-
ted to have an effect on the activity of the enzyme. 
More specifically, the inhibition of DNase I activity 
on native DNA by EB, DDMB, MAPEC and MAPAC was studied. The 
dependence of the inhibition of the enzyme on the added drug/ 
nucleotide ratio for these four drugs is shown in Figures 
48 - 51. Since the amount of DNA present in all complexes 
is the same, this presentation of the data is equivalent to 
one where percent inhibition is plotted versus total amount 
of inhibitor present. 
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Figure 48. Inhibition of pancreatic DNase by EB as a 
function of the added EB/nucleotide ratio. Buffer: 0.04 M 
Tris-HCl, 0.004 M MgS04 , 0.0017 ~ CaC12 , pH 7.9. Room 
temperature. 
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Figure 49. Inhibition of pancreatic DNase by DDMB 
as a function of the added DDMB/nucleotide ratio. Buffer: 
0.04 t!_Tris-HCl, 0.004 ~ Mgso4 , 0.0017 M Cac12 , pH 7.9. 
Room temperature. 
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Figure 50. Inhibition of pancreatic DNase by MAPEC 
as a function of the added MAPEC/nucleotide ratio. Buffer: 
0.04 ~ Tris-HCl, 0.004 M MgS04, 0.0017 tl CaClz, pH 7.9. 
Room temperature. 
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Figure 51. Inhibition of pancreatic DNase by MAPAC 
as a function of the added MAPAC/nucleotide ratio. Buffer: 
0.04 M Tris-HCl, 0.004 tl MgS04 , 0.0017 M CaC12 , pH 7.9. 
Room temperature. 
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Examination of the dependence of DNase inhibition on 
the added dye/nucleotide ratio reveals the presence of some 
differences in the inhibition effects of the phenanthridiniurn 
derivatives used in this study. However, no definite con-
clusions can be drawn as to the differences in the effective-
ness of these compounds as inhibitors without a knowledge of 
the mechanism whereby this inhibitory action is brought 
about. For this reason the question whether EB interferes 
with the substrate function of DNA or whether it affects the 
activity of the enzyme itself was investigated. 
Figure 52 shows the results of an experiment, in 
which the enzyme activity was studied as a function of DNA 
concentration, either in the absence or in the presence of 
EB. The results are plotted according to Lineweaver and 
Burk (Lineweaver and Burk, 1934) as the inverse of the ini-
tial velocity versus the inverse of the substrate concentra-
tion. Experimental points obtained either in the presence 
or in the absence of inhibitor fall on straight lines inter-
secting each other on the ordinate. This observation indi-
cates that the inhibition of DNase by these phenanthridiniurn 
compounds is related in a competitive fashion to the amount 
of DNA present and serves as strong evidence in support of 
the notion that EB has no effect on the enzyme itself, but 
rather interferes with the function of DNA as substrate. 
r 
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Figure 52. Effect of the variation of the concen-
tration of DNA substrate on the activity of pancreatic DNase 
in the absence (0) and in the presence of 2.7 x 10- 6 M EB 
(1). Buffer: 0.04 M Tris-HCl, 0.004 M MgS04 , 0.0017 M 
CaC12 , pH 7.9. Room temperature. 
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Further support for this mechanism of inhibition is 
provided by the observation that, when total inhibitor con-
centration, Dt, is plotted versus the inhibition function 
i/1-i, the experimental points can easily be fitted to a 
curve which passes through the origin of the axes and the 
initial and final parts of which are straight lines (Figures 
53 - 56). This behaviour corresponds exactly to the case 
where the inhibitor binds to the substrate at the same site 
as the enzyme; the inhibition is the result of a diminution 
of the number of substrate molecules susceptible to an attack 
by the enzyme (Reiner, 1959). From the values of the slopes 
of the two linear portions and the extrapolative intercept 
on the Dt axis, the association constants for the binding of 
the phenanthridinium drugs to DNA were calculated. These 
values are summarized in Table 7 along with the spectrophoto-
metrically (Results, Section 1.3) determined values. There 
is remarkable agreement between t he two sets of association 
constants determined by the two methods. 
In view of the observation that DNase inhibition 
appears to be due to the binding of the phenanthridinium in-
hibitors to the DNA substrate, perhaps a more meaningful way 
of presenting the data is in the form of dependence of in-
hibition on the amount of drug bound to DNA or, equivalently, 
on £· The amount of drug bound to DNA was calculated on the 
basis of the binding constants obtained in 0.04 M potassium 
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Figure 53. Inhibition of pancreatic DNase by EB. 
The data are plotted according to (Reiner, 1959). Buffer: 
0.04 ~ Tris-HCl, 0.004 ~ Mgso4 , 0.0017 M Cac12 , pH 7.9. 
Room temperature. 
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Figure 54. Inhibition of pancreatic DNase by DDMB. 
The data are plotted according to (Reiner, 1959). Buffer: 
0.04 ~ Tris-HCl, 0.004 M MgS04, 0.0017 M CaClz· pH 7.9. 
Room temperature. 
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Figure 55. Inhibition of pancreatic DNase by MAPEC~ 
The data are plotted according to (Reiner, 1959). Buffer: 
0.04 M Tris-HCl, 0.004 ~ MgS04, 0.0017 M CaClz, pH 7.9. 
Room temperature. 
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Figure 56. Inhibition of pancreatic DNase by MAPAC. 
Ihe data are plotted according to (Reiner, 1959). Buffer: 
0.04 M Tris-HCl, 0.004 tl MgS04 , 0.0017 M CaC12 , pH 7.9. 
Room temperature. 
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T A B L E 7 
Association constants for the binding of certain 
phenanthridinilllTI cOmpounds to DNA 
Compound 
EB 
DDMB 
MAP AC 
MAPEC 
Reiner plot(l) 
2.2 x 105 1/mole 
2.6 x 105 1/mole 
1.2 x 105 1/mole 
1.6 x 105 l/mole 
Scatchard plot(2 ) 
2.2 x 105 1/mole 
1.9 x 105 1/mole 
1.7 x 105 1/mole 
2.0 x 105 1/mole 
(l)Buffer: 0.04 M Tris-HCl, 4 mM MgS04 , 1.7 mM CaC12 , pH 7.9. 
( 2 )Buffer: 0.04 M potassilllTI phosphate, 8 mM MgC12 , pH 7.0. 
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phosphate, 0.008 M MgC12 , pH 7.0. Although these are not 
the exact conditions under which the DNase assay was perform-
ed, these binding constants are nevertheless very close to 
the values obtained under assay conditions (Table 7). 
The percent inhibition of DNase by phenanthridinium 
dyes, as a function of£, is shown in Figures 57-60. Certain 
features of these graphs deserve comment. 
The inhibition of DNase increases rapidly up to an 
r of approximately 0.025 which corresponds to about 25% 
inhibition of the enzyme activity. Beyond that point, the 
inhibition increases linearly with the concentration of 
DNA-bound drug with slopes that are similar for the four 
drugs tested. Small differences, however, may exist and 
they seem to indicate that a phenyl substituent at position 
6 (EB, MAPEC, MAPAC with slopes, respectively, or 548, 535, 
and 545) gives rise to more effective DNase inhibition than 
the 6-methyl substituent (DDMB with a slope of 498). 
The number of amino substituents on the phenanthri-
dinium ring apparently does not affect substantially the in-
hibitory effect of these compounds on the activity of DNase, 
as it is evident from a comparison of the slopes of the 
inhibition plots of a diamino compound (EB, slope = 548) 
and two monoamino compounds (MAPEC, slope = 535 and MAPAC, 
slope= 545). 
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Figure 57. Inhibition of pancreatic DNase by EB as 
a function of£· Buffer: 0.04 M Tris-HCl, 0.004 ~ Mgso4 , 
0.0017 ~ Cac12 , pH 7.9. Room temperature. 
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Figure 58. Inhibition of pancreatic DNase by DDMB 
as a function of£· Buffer: 0.04 ~ Tris-HCl, 0.004 M MgS04 , 
0.0017 M Cac12 , pH 7.9. Room temperature. 
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Figure 59. Inhibition of pancreatic DNase by MAPEC 
as a function of r. Buffer: 0.04 ~ Tris-HCl, 0.004 ~ Mgso4 , 
0.0017 ~ CaC12 , pH 7.9. Room temperature. 
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Figure 60. Inhibition of pancreatic DNase by MAPAC 
as a function of r. Buffer: 0.04 M Tris-HCl, 0.004 M Mgso4 , 
0.0017 M Cac12 , pH 7.9. Room temperature. 
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6. INHIBITION OF DNA POLYMERASE 
Additional information concerning the effect of the 
intercalated phenanthridinium drug on the conformation and 
stability of the DNA-drug complex can be obtained from the 
study of the effect of these compounds on the activity of 
DNA polymerase using this complex as template. Changes in 
the conformation of the DNA-dye complex due to intercalation 
of different phenanthridinium dyes are expected to alter 
the affinity of the enzyme for the template and result in 
altered overall enzymic activity. Furthermore, physical 
separation of the parent strands is known to be a pre-requi-
site for DNA replication. Agents stabilizing the double-
stranded conformation of the DNA are expected to have an 
overall inhibitory effect on the action of DNA polymerase. 
Therefore, since phenanthridinium drugs preferentially 
stabilize the double-helical form of DNA (Results, Section 
4), it appeared to be of interest to examine whether their 
DNA-stabilizing effect could be correlated with their in-
hibitory action on DNA polymerase. 
The effect of four phenanthridinium compounds on 
the activity of the Micrococcus luteus DNA polymerase was 
studied. The compounds used were: EB, DEMB, MAPEC and MAPAC. 
Initially, the amount of new DNA synthesis was stu-
died as a function of the time of incubation of the assay 
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mixture at 37°C. As evidenced from the results shown in 
Figure 61, the amount of DNA synthesized is directly propor-
tional to the incubation time, at least up to 40 min. In 
subsequent experiments, incubation time was limited to 30 
min. 
The percent inhibition of DNA polymerase as a func-
tion of the added dye/nucleotide ratio is shown in Figures 
62 - 65. For all four drugs tested, the inhibition increases 
very rapidly for low added ratios, but appears to level off 
after a ratio of, about, 0.25. At this value, approximately 
80% inhibition of the polymerase activity is observed. 
Of course, no definite comparison between the in-
hibitory action of these phenanthridinium compounds on DNA 
polymerase activity is possible without som~ knowledge of 
the mechanism of their action and, specifically, without 
knowing whether the inhibition of the polymerase activity 
is due to the interaction of the inhibitor with the DNA tern-
plate or with the enzyme itself. In order to answer this,: 
question, four experiments were carried out, in which the 
amount of new DNA synthesized was studied as a function of 
the concentration of the DNA template, both in the absence 
and in the presence of phenanthridinium inhibitors. The 
results were plotted according to Lineweaver and Burk as the 
inverse of the amount of newly synthesized DNA versus the 
inverse of the concentration of the template and are shown 
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Figure 61. Time dependence of DNA synthesis by 
Micrococcus luteus DNA polymerase I. The reaction mixture 
contained, in 0.3 ml, 0.04 M potassium phosphate, pH 7.0; 
0.008 M MgC12 ; 0.33 mg/ml BSA; 0.001 M 2-mercaptoethanol; 
0.1 mtl each of dATP, dGTP, dCTP; 0.1 mM of tritiated TIP 
(approximately 15000 cpm/nmole); 8 µg/ml enzyme; temperature: 
37°c. 
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Figure 62. Inhibition of DNA polymerase by EB as a 
function of the added EB/nucleotide ratio. The reaction 
mixture contained, in 0.3 ml, 0.04 M potassium phosphate, 
pH 7.0; 0.008 M MgC12 ; 0.33 mg/ml BSA; 0.001 M 2-mercapto-
ethanol; 0.1 mM each of dATP, dGTP, dCTP; 0.1 mM of tritia-
ted TIP (approximately 15000 cpm/nmole); 8 µg/ml enzyme; 
0.072 mg/ml activated calf thymus DNA. Temperature: 37°c. 
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Figure 63. Inhibition of DNA polymerase by DEMB as 
a function of the added DEMB/nucleotide ratio. The reaction 
mixture contained, in 0.3 ml, 0.04 M potassium phosphate, 
pH 7.0; 0.008 M MgC12 , 0.33 mg/ml BSA; 0.001 M 2-mercapto-
ethanol; 0.1 mtl each of dATP, dGTP, dCTP; 0.1 mM of tritiated 
TTP (approximately 15000 cpm/nmole); 8 µg/ml enzyme; 0.072 
mg/ml activated calf thymus DNA. Temperature: 37°C. 
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Figure 64. Inhibition of DNA polymerase by MAPEC as 
a function of the added MAPEC/nucleotide ratio. The reaction 
mixture contained, in 0.3 ml, 0.04 M potassium phosphate, 
pH 7.0; 0.008 M MgC12 ; 0.33 mg/ml BSA; 0.001 M 2-mercapto-
ethanol; 0.1 mM·each of dATP, dGTP, dCTP; 0.1 mM of tritia-
ted TTP (approximately 15000 cpm/nmole); 8 µg/ml enzyme; 
0.072 mg/ml activated calf thymus DNA. Temperature: 37°C. 
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Figure 65. Inhibition of DNA polymerase by MAPAC as 
a function of the added MAPAC/nucleotide ratio. The reaction 
mixture contained, in 0.3 ml, 0.04 M potassium phosphate, 
pH 7.0; 0.008 tl_MgCl2; 0.33 mg/ml BSA; 0.001 M 
2-mercaptoethanol; 0.1 mM each of dATP, dGTP, dCTP; 0.1 rnM 
of tritiated TIP (approximately 15000 cpm/nrnole); 8 µg/ml 
enzyme; 0.072 mg/ml activated calf thymus DNA. Temperature: 
37°c. 
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in Figures 66 - 69. With all four compounds studied, 
straight lines can be drawn through the experimental points 
obtained both in the presence and in the absence of inhibitor. 
These two lines intersect each other on the l/v axis, thus 
indicating that the inhibition of DNA polymerase by these 
phenanthridinium compounds is competitive with the concen-
tration of the DNA template. This finding is in complete 
agreement with, and further supports, the notion that the 
inhibitory effect of these compounds on DNA polymerase is 
due to the formation of a complex between the dyes and the 
template. A similar observation was reported (Waring, 1965a) 
for the inhibition of the DNA-dependent RNA polymerase acti-
vity by EB, indicating a similar mode of inhibition of the 
two enzyme systems by EB. 
Since the DNA polymerase inhibition seems to result 
from the interaction of the drug with the template, a more 
meaningful way of presenting the inhibition data is, perhaps, 
as a function of the template-bound inhibitor or, equivalent-
ly, as a function of r (Figures 70 - 73). The amount of 
template-bound drug is estimated by means of the binding 
constants obtained under assay conditions (Results, Section 
1.3). 
The inhibition of DNA polymerase by the four phenan-
thridinium drugs tested depends very strongly on the con-
centration of the DNA-drug complex and, at low r values 9 
r 
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Figure 66. Effect of the variation of the concen-
tration of DNA template on the activity of DNA polymerase in 
the absence (4) and in the presence of 4.3 x 10- 6 M EB (~). 
The reaction mixture contained, in 0.3 ml, 0.04 ~ potassium 
phosphate, pH 7.0; 0.008 ~ MgC12 ; 0.33 mg/ml BSA; 0.001 M 
2-mercaptoethanol; 0.1 mM each of dATP, dGTP, dCTP; 0.1 mM 
of tritiated TIP (approximately 15000 cpm/nmole); 8 µg/ml 
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Figure 67. Effect of the variation of the concen-
tration of DNA template on the activity of DNA polymerase in 
the absence (~) and in the presence of 6 x 10- 6 M DEMB (~). 
The reaction mixture contained, in 0.3 ml, 0.04 M potassium 
phosphate, pH 7.0; 0.008 ~ MgC12 ; 0.33 mg/ml BSA; 0.001 M 
2-mercaptoethanol; 0.1 rnM each of dATP,· dGTP, dCTP; 0.1 rnM 
of tritiated TIP (approximately 15000 cpm/nmole); 8 µg/ml 
enzyme; temperature: 37°c. 
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Figure 68. Effect of the variation of the concen-
tration of DNA template on the activity of DNA polymerase in 
the absence (A) and in the presence of 4.5 x 10- 6 M 
. 
MAPEC (6). The reaction mixture contained, in 0.3 ml, 
0.04 M potassium phosphate, pH 7.0; 0.008 M MgC12 ; 
0.33 mg/ml BSA; 0.001 M 2-mercaptoetha~ol; 0.1 mM each of 
dATP, dGTP, dCTP; 0.1 mM of tritiated TIP (approximately 
15000 cpm/nmole); 8 µg/ml enzyme; temperature: 37°c. 
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Figure 69. Effect of the variation of the concen-
tration of DNA template on the activity of DNA polymerase in 
the absence (A) and in the presence of 6 x 10- 6 M MAPAC (A). 
The reaction mixture contained, in 0.3 ml, 0.04 M potassium 
phosphate, pH 7.0; 0.008 ~ MgC12 ; 0.33 mg/ml BSA; 0.001 M 
2-mercaptoethanol; 0 .1 mM each of dATP '· dGTP, dCTP; 0 .1 mM 
of tritiated TTP (approximately 15000 cpm/nmole); 8 µg/ml 
enz:Yme; temperature: 37°C. 
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Figure 70. Inhibition of DNA polymerase by EB as 
a function of .£• The reaction mixture contained, in 0.3 ml, 
0.04 M potassium phosphate, pH 7.0; 0.008 M MgC12 ; 
0.33 mg/ml BSA; 0.001 M 2-mercaptoethanol; 0.1 mM each of 
dATP, dGTP, dCTP; 0.1 mM of tritiated TTP (approximately 
15000 cpm/nmole); 8 µg/ml enzyme; 0.072 mg/ml activated 
calf thymus DNA. Temperature: 37°c. 
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Figure 71. Inhibition of DNA polymerase by DEMB as 
a function of £· The reaction mixture contained, in 0.3 ml, 
0.04 M potassium phosphate, pH 7.0; 0.008 M MgC12 ; 0.33 mg/ml 
BSA; 0.001 M 2-mercaptoethanol; 0.1 raM each of dATP, dGTP, 
dCTP; 0.1 mtl of tritiated TIP (approximately 15000 cpm/nmole); 
8 pg/ml enzyme; 0.072 mg/ml activated calf thymus DNA. 
Temperature: 37°c. 
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Figure 72. Inhibition of DNA polymerase by MAPEC 
as a function of r. The reaction mixture contained, in 
0.3 ml, 0.04 M potassium phosphate, pH 7.0; 0.008 M MgC12 : 
0.33 mg/ml BSA; 0.001 ~ 2-mercaptoethanol; 0.1 mt! each of 
dATP, dGTP, dCTP; 0.1 m~ of tritiated TIP (approximately 
15000 cpm/nmole); 8 µg/ml enzyme; 0.072 mg/ml activated 
calf thymus DNA. Temperature: 37°C. 
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Figure 73. Inhibition of DNA polymerase by MAPAC 
as a function of £· The reaction mixture contained, in 
0.3 ml, 0.04 M potassium phosphate, pH 7.0; 0.008 M MgC12 ; 
0.33 mg/ml BSA; 0.001 tl 2-mercaptoethanol; 0.1 mM each of 
dATP, dGTP, dCTP; 0.1 ~of tritiated TTP (approximately 
15000 cpm/nmole); 8 µg/ml enzyme; 0.072 mg/ml activated calf 
thymus DNA. Temperature: 37°c. 
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it increases rapidly with r so that the activity of the 
polymerase is already reduced by 50% at an £ value of 
approximately 0.05,. i.e. when, on the average, one drug 
molecule is bound per 10 base pairs. However, at higher 
concentrations of the DNA-drug complex, the rate of inhibi-
tion gradually decreases and certain differences in the 
inhibitory effect of these drugs on DNA polymerase activity 
become apparent. Indeed, 90% inhibition with MAPEC is 
observed at an £ value of 0.13, with MAPAC at an r of 0.14 
and with EB at an r of 0.15, whereas with DEMB, such level 
of inhibition is not observed until an£ of 0.18 is reached. 
It is interesting to note that DEMB, the compound that 
appears as the weakest inhibitor, is the only one among the 
four derivatives studied in which the 6-phenyl substituent 
has been replaced by a relatively smaller ethyl group. 
This observation suggests that the size of the substituent 
at position 6 of the phenanthridinium ring plays some role 
in determining the extent of DNA polymerase inhibition by 
the phenanthridinium compounds. 
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DISCUSSION 
1. FACTORS INFLUENCING THE STABILITY OF THE COMPLEX 
It is generally accepted that intercalation of 
phenanthridinium compounds to DNA places the phenanthridinium 
ring between two successive base pairs 'in an orientation 
approximately perpendicular to the helix axis. Stabilization 
energy for the formation of this complex is provided mainly 
by hydrophobic forces between the phenanthridinium ring and 
the DNA bases. Additional stabilization is afforded by 
hydrogen bonds formed between the amino substituents at posi-
tions 3 and 8 of the intercalated molecule and the phosphate 
groups at the two DNA strands. 
The above model, proposed initially for EB (Fuller 
and Waring, 1964), appears to be equally valid for the rest 
of the phenanthridinium compounds examined in this investi-
gation. Indeed, measurements of the unwinding angle of 
supercoiled DNA in the presence of phenanthridinium deriva-
tives suggest that the absence of one or even both amino 
groups at positions 3 and 8 of the ring does not affect 
appreciably the ability of these compounds to intercalate 
(Wakelin and Waring, 1974). The major component of the 
energy of formation of the phenanthridinium-DNA complex is 
derived from the hydrophobic interactions mentioned above, 
as indicated by the effect of the phenanthridinium derivatives 
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on the thermal stability of the DNA. On the basis of the 
evidence obtained from the binding studies, it appears that 
the extent of double-stranded DNA stabilization against 
thermal denaturation is the same for derivatives with the 
amino groups at both the c3 and c8 positions of the ring, 
as well as for those with only the 8-amino substituent. The 
absence of any differential stabilization of the complex by 
mono- or diamino-phenanthridinium derivatives indicates that 
a hydrogen bond between the 3-amino group of the intercalated 
molecule and a DNA phosphate residue does not contribute sig-
nificantly to the overall stabilization of the complex, at 
least at melting temperatures. Indeed, it was estimated 
(Wakelin and Waring, 1974) that each of the two hydrogen 
bonds (involving the 3- and 8-amino groups of the molecule) 
contributes approximately 0.85 kcal/mole to the stability 
of the complex. A contribution of 0.7 kcal/mole for the· 
hydrogen bond involving the 3-amino group may be calculated 
from the association constant values of EB and MAPEC 
(Table 1), with the assumption that the 2- amino group of 
MAPEC does not affect the stability of the complex. Clearly, 
such small differences in the free energy of formation of 
the complex are not expected to result in any measurable 
differential effect on the melting temperature of the 
phenanthridinium-DNA complex. 
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Small differences in complex stabilizing energy are 
more easily detectable at lower temperatures. Indeed, such 
differences are expressed in the association constant values 
calculated for the binding of the phenanthridinium compounds 
to DNA. Although, at any one set of experimental conditions 
used, major differences in the binding 'properties of the 
drugs were not observed, small differences do exist, both in 
the intrinsic association constant and in the number of 
binding sites. Significantly, these differences are more 
pronounced under conditions of low temperature and low ionic 
strength, whereas at 37°C and moderately high ionic strength 
the association constants are almost the same for both mono-
and diamino derivatives. These observations are consistent 
with the model of Fuller and Waring presented above and in-
dicate that hydrogen bonds between the 3 and 8 amino groups 
of the phenanthridinium molecule and the DNA phosphates con-
tribute a small but measurable fraction of the complex 
stabilizing energy. Therefore, the slightly weaker binding 
of the monoamino derivatives can be explained by their lack 
of the amino group at position c3 which would provide the 
opportunity for a second hydrogen bond with DNA. 
Another interesting feature of the Tm profiles of 
the dye-DNA complexes is the observed increase in the width 
of the transition u~on binding of the drugs to the nucleic . 
acid. This widening of the melting transition is consistent 
r 
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with the "reintercalation" mechanism proposed earlier 
(Aktipis et al., 1975). It was observed that, during ther-
mal denaturation of the EB-DNA complex, the molar ellipti-
city at 310 nm increases sharply shortly after the onset of 
strand separation. This increase was interpreted as indica-
tive of reintercalation of EB molecules that had been 
released from the already melted regions of the complex. 
It may be assumed that, at room temperature, the EB mole-
cules are randomly and uniformly distributed over the length 
of the DNA molecule. As the temperature is increased, how-
ever, certain regions of DNA tend to melt first. EB mole-
cules intercalated in these regions are released and re-
intercalate at more stable DNA regions which retain their 
double-stranded form at this temperature. This process of 
rearrangement of intercalated molecules results in a loca-
lized increase of the drug/nucleotide ratio. Since the . 
thermal stability of the DNA increases with the increasing 
EB/nucleotide ratio (Martz, 1971; Waring, 1974), it is ex-
pected that the intercalation of these drug molecules to 
the as yet unmelted DNA regions will stabilize these regions 
further. The net result would be widening of the melting 
transition of the phenanthridinium-DNA complex as compared 
with the breadth of the transition of free DNA. 
Alternatively, the widening of the melting transi-
tion of the DNA-dye complex may be considered as an indica-
tion of the distribution of the intercalated molecules over 
r 
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the DNA helix. In the conditions under which the Tm experi-
ments were performed there is, on the average, one dye mole-
cule bound per five base pairs. The base pairs in the 
immediate vicinity of the intercalated molecule, i.e. the 
ones immediately above and below it, will be the most 
stabilized and, therefore, will melt at a temperature sig-
nificantly higher than their respective melting temperature 
in free DNA. 
However, because of the cooperative character of the 
melting of the DNA, the base pairs between, but not in the 
immediate vicinity of, two intercalated dye molecules will 
also be stabilized, although to a lesser degree. This 
differential stabilization would, of course, result in 
differences in the melting temperatures of the various groups 
of base pairs and these differences could be reflected in 
the widening of the overall melting transition of the dye-
ol 
DNA complex. 
2. INFORMATION ON THE CONFORMATION OF THE COMPLEX OBTAINED 
BY PHYSICAL METHODS 
As already indicated in the Introduction, one of the 
major goals of this investigation concerns the relationship 
between the chemical structure of the intercalated phenan-
thridinium derivatives and the conformation of the 
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phenanthridinium-DNA complex. Specifically, the conforma-
tion of the complex is examined as a function of the primary 
amino groups at positions 3 and·8 of the dye molecule. In-
formation concerning the conformation of the phenanthri-
diniurn-DNA complex presented in this dissertation is derived 
mainly from the results of the circulaE dichroism and fluo-
rescence experiments. 
2.1. Differences in the origin of the CD bands of the complex 
Circular dichroism, as a phenomenon, expresses the 
differential absorption of right and left circularly pola-
rized light by an optically active chromophore. Since cir-
cular dichroism is a result of differences in absorption of 
light, it is observed in the vicinity of the absorption bands 
of the compound under study. The wavelength, therefore, at 
which the optical activity of a chromophore is manifested, 
is determined inherently by the molecular structure of that 
chromophore. Optical activity may be inherent in the chromo-
phore, because of its intrinsic configuration, or, alterna-
tively, it may be induced by an asymmetric environment in a 
chromophore which is, by itself, optically inactive. 
The circular dichroism observed in the 300-600 nm 
region when phenanthridiniurn drugs bind to DNA is of the 
second type of optical activity discussed above, namely in-
duced optical activity. The DNA molecule alone, despite its 
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structural assyrnmetry, does not display any optical activity 
at wavelengths longer than 300 nm, because absorption of 
light by this macromolecule is insignificant in this region. 
Similarly, the phenanthridinium drugs studied, despite the 
presence of strong absorption bands in the wavelength region 
between 300 and 600 nm, are not intrinsically asymmetric and 
are, therefore, optically inactive. 
Consequently, the ellipticity observed when phenan-
thridinium compounds bind to DNA may be the expression of , 
optical activity induced in the optically inactive chromo-
phore of the bound dye by the asymmetric environment of the 
nucleic acid (Yamaoka and Resnik, 1966). Alternatively, the 
possibility exists, especially at high bound drug/nucleotide 
ratios, that interactions among the intercalated dye mole-
cules produce or contribute to the optical activity of the 
complex (Gardner and Mason, 1967). 
Since the CD properties of the DNA-phenanthridinium 
complexes in the short (300 - 315 nm) wavelength region are 
radically different from those noted in the long (470 - 500 
nm) wavelength region, bands with maxima in these two regions 
must be attributed to different sources of asymmetry. 
Specifically, the characteristics of the long wave-
length band, i.e. appearance of optical activity even at low 
bound drug/nucleotide ratios and independence of the molar 
ellipticity from this ratio, suggest that ellipticity at this 
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region is not influenced by the distance between intercala-
ted molecules. It appears, therefore, that optical activity 
in the 470-500 nm region is the result of interactions of the 
first type described above, i.e. optical activity in this 
region results from the influence of the surrounding asymme-
tric polynucleotide structure on the intercalated molecule. 
In contrast, the ellipticity at the short (300-315 nm) 
wavelength band exhibits a behavior which indicates a dis-
tinctly different origin. Specifically, the increase of 
molar ellipticity of the diamino drug-DNA complexes at 310 nm 
with increasing £ indicates that each bound dye molecule 
contributes more to the optical activity when the intercala-
ted molecules are more densely distributed over the DNA 
helix. Therefore, ellipticity at 310 nm appears to originate 
from the second type of interaction described above, namely 
interactions between dye molecules intercalated at neigh-
boring sites. 
2.2. The origin of the 310 nm CD band 
Because of this unusual behavior of the molar ellip-
ticity at 310 nm, the origin of the 310 nm band was investi-
gated in more detail. 
A similar dependence of molar ellipticity on dye/ 
nucleotide ratio was observed in the proflavine-DNA system 
and two possible mechanisms were proposed to explain the 
phenomenon: 
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1. The increase in molar ellipticity is the result 
of direct interactions between intercalated dye molecules. 
The possibility of such interaction, of course increases as 
the number of molecules bound within a given segment of the 
DNA increases (Blake and Peacocke, 1967). 
2. Alternatively, the variation in optical activi-
ty may be due to an alteration of the conformation of the 
drug binding site, resulting from intercalation of additio-
nal dye molecules at neighboring sites (Dalgleish et al., 
1969). In this case also, the probability of a dye mole-
cule intercalating to a site adjacent to one already occu-
pied by another molecule increases as the number of bound 
dye molecules per, nucleotide increases. 
All currently available experimental evidence is 
compatible with either one of the above models, so that 
elimination of one in favor of the other is not possible,, 
at this time. 'In fact, the lack of theoretical predictions 
as to the characteristics of the CD resulting from the 
second type of interactions renders that model inaccessible 
to direct experimental verification. In contrast, according 
to Tinoco (Tinoco, 1964), direct interactions between the 
intercalated dye molecules which form a helical array are 
expected to give rise to a doublet of positive and negative 
peaks in the CD spectrum. In fact, there is an indication 
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of such a doublet centered at approximately 300 nm in the CD 
spectrum of the EB-DNA complex (Figures 16 and 31). The 
negative component of this probable doublet is not easily 
detectable at low ionic strength, probably because of a 
mutually cancelling effect between this band and the strong 
positive band of the DNA spectrum at 270 nm. 
The existence of the conservative doublet in the CD 
spectrum of the EB-DNA complex lends support to the notion 
that direct interactions between EB molecules intercalated 
at neighboring sites are important contributors to the CD 
of the complex in the 300 nm region at high ionic strength. 
Furthermore, this conclusion may be expanded to low ionic 
strength conditions if it is assumed that the conformation 
of the complex is not significantly affected by increased 
salt concentration. There are indeed indications that, aside 
from a minor change in the average angle of rotation of the 
helix, the conformation of the DNA is not particularly sensi-
tive to salt (Wang, 1969; Studdert et al., 1972). The simi-
larities of the CD of the complex in 0.04 M Tris and in 
5.0 M NaCl indicate that a similar condition may apply to the 
EB-DNA complex. 
Another question which may be considered is whether 
these interactions between dye molecules intercalated at 
adjacent sites are transmitted through the intervening base 
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base pairs or whether they occur in some other more direct 
manner. According to the original intercalation model 
(Fuller and Waring, 1964), the phenanthridinium ring is 
completely immersed in the space between the base pairs and 
no part of it is accessible for direct interactions between 
intercalated molecules. The model, however, postulates that 
the 5- and 6-substituents of the drug are situated within 
the large groove of the helix. The possibility, therefore, 
exists that the interactions mentioned above could occur 
via these groups and especially the 6-phenyl substituent of 
the EB molecule. The behavior of the CD of the DDMB-DNA 
complex is an indication to the contrary. DDMB is the 5,6-
dimethyl analogue of EB and the CD spectrum of its complex 
with DNA is both qualitatively and quantitatively very simi-
lar to that of the EB-DNA complex. This finding is an indi-
cation that, if interactions between phenyl groups of inter-
calated EB molecules occur to any significant degree, such 
interactions do not contribute appreciably to the CD of the 
complex near 300 nm. 
It appears, therefore, that interactions between 
intercalated diamino phenanthridinium molecules are exerted 
from one drug molecule to the other mainly via the interve-
ning base pairs. 
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2.3. Differences in the properties of DNA complexes of mono-
and diamino phenanthridinium dyes 
2.3.1. CD evidence 
In comparison with the spectra of the complexes of 
the diamino phenanthridinium dyes with DNA, the CD spectra 
below 350 nm of the monoamino phenanthridinium-DNA complexes 
appear distinctly different, both in terms of shape as well 
as magnitude. Although molar ellipticity near 310 nm appears 
to depend on r, the observed increase in £1 - ~r is much 
weaker than that exhibited by the diamino phenanthridinium 
complexes. In addition, and perhaps more significantly, 
the shape of the CD spectrum itself changes with increasing 
dye/nucleotide ratio. Considering that changes in CD fre-
quently reflect changes in the conformation of the macro-
molecule under study, this observation might be considered 
as indicative of differences in the conformation of the 
drug-DNA complex, depending on whether a mono- or a diamino 
phenanthridinium compound is intercalated. 
Such differences in the circular dichroism spectra 
of the two classes of complexes are not unexpected, if 
certain conditions necessary for inducing optical activity 
are taken into consideration. Induction of optical activity 
requires that the intercalated molecules be maintained in a 
specific orientation with respect to one another (Yamaoka 
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and Resnik, 1966). Molecules, therefore, not properly 
oriented within their intercalation sites would not be ex-
pected to exhibit strong induced optical activity. 
According to the model originally proposed by Fuller 
and Waring for the DNA-EB complex, the primary amino groups 
at positions 3 and 8 of the EB molecule contribute. to the 
overall stabilization of the complex by forming hydrogen 
bonds with the phosphate groups on the backbone of the helix. 
Conceivably, these hydrogen bonds may also contribute in 
maintaining the intercalated molecule in a specific orien-
tation within its binding site. The possibility of such a 
role for the c3 and the c8 amino groups was also considered 
recently (Wakelin and Waring, 1974) but a direct experimen-
tal testing of this possibility was not attempted. This 
orientation seems to be the most favorable for near neighbor 
interactions and it may be responsible for the increased· 
optical activity observed with complexes formed between DNA 
and EB or DDMB. 
Furthermore, this particular positioning may be 
difficult to maintain when the intercalated molecule lacks 
the amino group at the c3 position. The absence of the 
hydrogen bond between that gro~p and a DNA phosphate would 
be expected to increase the freedom of movement of the inter-
calated molecule within its binding site. Thus, the inter-
calated molecule would not be restricted to the specific 
r 
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orientation associated with strong optical activity near 
310 run, which would result in the significantly reduced 
ellipticity in the 300-350 run region observed for the com-
plexes of DNA with MAPAC, MAPEC or MMPB. 
2.3.2. Fluorescence evidence 
The existence of differences in the conformation of 
the phenanthridinium-DNA complexes is further confirmed by 
the considerable increase in the fluorescence of the diamino 
compounds upon binding to DNA, whereas, under identical con-
ditions, only a slight increase, if any, is observed with 
the monoamino derivatives. 
Immersion of the intercalated molecule in the hydro-
phobic interior of DNA has been implicated as the reason for 
the increased fluorescence of intercalated EB molecules 
(LePecq and Paoletti, 1967). The main argument supporting 
this conclusion was the observed increase in the quantum 
efficiency of EB in nonpolar solvents. It was reported that, 
when EB is dissolved in ethylene glycol, methanol, ethanol, 
propanol, butanol or octanol, its quantum efficiency increa-
ses from ethylene glycol to ethanol. The quantum efficien-
cy in ethanol is about six times greater than in water, but 
it decreases slightly from ethanol to octanol (LePecq and 
Paoletti, 1967). Similar observations were reported for 
various other aromatic hydrocarbons, the fluorescence 
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intensity of which increases with decreasing solvent polari-_ 
ty (Majumdar and Basu, 1960; Van Duuren, 1963; Stryer, 
1965). 
The differences, therefore, observed in the fluores-
cence enhancement between the mono- and the diamino phenan-
thridinium compounds may be an indication that these two 
classes of compounds interact to different extents with the 
hydrophobic environment of the nucleic acid. 
By studying the decay of the emission anisotropy of 
the EB-DNA complex, Wahl and his co-workers (Wahl et al., 
1970) obtained evidence that the intercalated drug molecules 
are subject to internal Brownian motion. This motion consists 
of an oscillation of the bound molecules within their plane 
of intercalation. The angle of the oscillation was estimated 
to approximately 35°. This angle is probably limited by 
the two hydrogen bonds formed between the two amino groups 
of the EB molecule and the phosphate groups on the two DNA 
strands. The intercalated molecule is, therefore, only 
following the transient local unwinding ("breathing") of the 
helix (Wahl et al., 1970). 
In contrast, such a topological restriction is 
probably not imposed upon the monoamino compounds. These 
molecules lack the amino group at the c3 position. Conse-
quently, they can only form one hydrogen bond, namely that 
between their 8-amino group and a DNA phosphate group. 
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Therefore, the freedom of oscillation of monoamino phenan-
thridinium compounds within their intercalation plane is 
expected to be higher than that of the diamino compounds 
and the field of movement of the monoamino derivatives is 
not restricted to the hydrophobic volume between successive 
base pairs, but may extend into the aqueous environment 
surrounding the nucleic acid as well. Put in another way, 
if two types of environment are considered, i.e. a hydro-
phobic one, between the DNA base pairs, and an aqueous, 
surrounding the DNA-drug complex, then the distribution of 
the diamino compounds in the hydrophobic medium at any given 
moment is expected to be higher than the corresponding 
distribution of the monoamino derivatives. 
However, as it was mentioned earlier, the polarity 
of the environment has a profound effect on the quantum 
yield of aromatic compounds. It has been reported that the 
quantum yield of at least one such compound, l-anilino-8-
napthalene sulfonate (ANS), decreases dramatically with 
increasing water content of the solvent (Stryer, 1965). 
Therefore, the, even partial, immersion of the monoamino 
phenanthridinium dyes into an aqueous environment would be 
expected to have a considerable quenching effect on their 
fluorescence intensity. On the other hand, the quantum 
efficiency of the intercalated diamino derivatives would be 
expected to increase considerably over that of the free dye, 
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since these compounds are almost always located within the 
less polar environment of the interior of the nucleic acid. 
The above model of differential distribution of 
mono- and diamino compounds into the hydrophobic environ-
ment of the DNA base pairs also provides an explanation for 
the modest increase in fluorescence of MMPB upon binding to 
DNA. As indicated in the Results (Section 3), the fluores-
cence of MMPB increases approximately 5-fold upon binding to 
DNA, whereas the fluorescence of the other two monoamino 
drugs studied, MAPAC and MAPEC, shows no significant changes. 
This difference on fluorescence enhancement may be an indi-
cation that the exposure of MAPAC and MAPEC to the aqueous 
environment of the solution is higher than that of MMPB. 
The reason for this may lie in the differences in the sub-
stituents at the c6 position between MMPB and the other two 
monoamino phenanthridinium derivatives. The c6 substituents, 
according to the original intercalation model (Fuller and 
Waring, 1964), are situated within the major groove of the 
DNA helix and are in contact with the medium surrounding 
the polynucleotide. It is expected, therefore, that the 
relatively more polar Q-aminophenyl group at position c6 of 
MAPAC and MAPEC will tend to increase the exposure of the 
phenanthridinium ring to the aqueous environment more than 
the relatively more hydrophobic 6-phenyl substituent of MMPB. 
158 
3. THE COMPLEX AS AN ENZYMIC SUBSTRATE 
The conformation and stability of the phenanthridi-
nium-DNA complex are expected to affect the ability of this 
complex to serve as template or substrate for DNA polymerase 
or DNase respectively. Both DNA polymerase and DNase have 
well defined requirements regarding the conformation of the 
nucleic acid that serves as their respective template or 
substrate (Zimmermann, 1966; Harwood et al., 1970a; Junowicz 
and Spencer, 1973; Ehrlich et al., 1973). Therefore, agents 
that affect the DNA conformation will very likely influence 
the affinity of these enzymes for the nucleic acid and this 
influence will be reflected in the rate of the enzymic 
reaction. 
3.1. Modification of the DNA substrate as a result of dye 
binding 
It has been well established that binding of phenan-
thridinium compounds alters the topological characteristics 
of DNA (Wakelin and Waring, 1974); it has been estimated that 
each intercalated molecule unwinds the DNA helix by 8 - 12° 
(Pigram et al., 1973; Wakelin and Waring, 1974) and possibly 
by as much as 26° (Wang, 1974) .. Even if it is assumed that 
the change in the conformation of the DNA induced by dye 
binding is not being transmitted more than a few base pairs 
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along the helix, the overall conformational change will be 
proportional to the number of drug molecules bound to it. 
Since the ability of an enzyme to recognize its substrate 
and bind effectively to it depends on the conformation of the 
substrate, it should be expected that the activity of the 
enzyme be inversely related to the concentration of the 
bound dye. 
A possible alternative to the mechanism of inhibi-
tion just described involves the substituents of the phenan-
thridiniurn molecules at positions 5 and 6 of the ring. 
According to the original intercalative model of Fuller and 
Waring (1964), these groups are not inserted between the 
base pairs but lie in the large groove of the helix. There-
fore, they probably do not affect directly the DNA confor-
mation (Results, Section 2), but they may reduce the affinity 
of the enzyme for its substrate by sterically preventing the 
binding of the enzyme to DNA. Specifically, molecules with 
bulky groups at the 5 and/or 6 positions of the ring would be 
expected to be more effective inhibitors of the enzyme acti-
vity than the derivatives with small alkyl groups at these 
positions. 
Finally, enzymic inhibition may result from the 
stabilization of the double-stranded form of DNA. It was 
shown that the phenanthridiniurn compounds preferentially 
stabilize that form (Results, Section 4) and that this sta-
bilization increases with increasing added dye/nucleotide 
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ratio (Martz, 1971; Waring, 1974). Therefore, if the enzyme 
requires a single-stranded substrate (or template), this 
preferential stabilization of double-helical DNA will result 
in decreased enzymic activity. 
The three possible mechanisms of inhibition des-
cribed above appear to participate, alb~it to different 
extent in each case, to the inhibition of DNase and DNA 
polymerase by the phenanthridinium compounds. 
3.2. Inhibition of DNase 
The first two mechanisms, namely those involving 
conformational change of the substrate and physical preven-
tion of binding, appear to play a major role in the inhibi-
tion of DNase. On the contrary, stabilization of the DNA 
double-helix is not expected to be a significant factor in 
the inhibition of this enzyme, since DNase I is, in fact, 
known to hydrolyze native DNA faster than denatured DNA 
(Dirksen and Dekker, 1958). 
The effect of the dye-DNA complex conformation on 
the activity of DNase is indicated by the linear dependence 
of the inhibition of this enzyme on the.bound dye/nucleotide 
ratio, as suggested by the inhibition mechanism (Discussion, 
Section 3.1). In addition, the different rates of DNase 
inhibition observed with different phenanthridinium deriva-
tives indicate that the groups at positions 5 and/or 6 of 
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the ring contribute to the inhibition of DNase by these 
compounds. Indeed, as judged from the slopes in the linear 
portion of the dependence of enzyme inhibition on £, it 
appears that drugs with a 6-phenyl substituent are somewhat 
stronger inhibitors than the 5,6-dimethyl derivative. 
3.3. Inhibition of DNA polymerase 
In contrast, in the case of DNA polymerase, the 
above two factors affecting inhibition, i.e. conformational 
change of the template and physical prevention of binding, 
are not expected to affect significantly the activity of the 
enzyme, at least as far as its initial binding to the template 
is concerned, under the experimental conditions used. This 
is because the template used for the assay was "activated", 
i.e. the DNA was pretreated briefly with DNase so that 
single-stranded nicks were introduced to it. It has been· 
shown (Kornberg, 1969) that DNA polymerase binds preferen-
tially and quantitatively to single stranded nicks of the 
template. However, it is in the immediate vicinity of the 
nicks that the double-helical structure of the DNA is the 
less stable. Since EB is known to bind preferentially to 
the double-stranded structure, the density of the intercala-
ted molecules population close to the nicks would be sig-
nificantly lower than the average density for the remaining 
DNA molecule. It follows, therefore, that, since nicks 
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constitute major polymerase binding sites, the intercala-
tion of phenanthridinium compounds to DNA will not affect 
significantly the binding of the polymerase to its template. 
Although the initial binding of the polymerase to 
its template may not be substantially inhibited by the 
intercalated phenanthridinium dyes, the propagation of the 
enzyme along the DNA molecule could be hindered by the pre-
sence of these compounds. Undoubtedly, a major part of this 
inhibition of propagation is due to the stabilization of the 
double-helical form of the DNA by the intercalated dye. The 
physical separation of the two parent strands during DNA 
replication was established with the classical experiments 
of Meselson and Stahl (Meselson and Stahl, 1958), as well as 
with subsequent studies with similar aims (Cairns, 1962; 
Baldwin and Shooter, 1963). Agents, therefore, inhibiting 
this strand separation would effectively inhibit replication 
of DNA. 
Since phenanthridinium dyes preferentially stabilize 
the helical form of DNA, as evidenced by the increased Tm 
values of the dye-DNA complexes (Results, Section 4), it is 
not surprising that replication of DNA is substantially in-
hibited in the presence of these compounds. Evidence suppor-
ting such a relationship between stabilization of the DNA 
double-helix and inhibition of DNA polymerase is provided 
by the similarity of the dependence of these two properties 
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on the added dye/nucleotide ratio. Indeed, the dependence 
of inhibition of DNA polymerase versus added EB/DNA ratio 
(Figure 62) is very similar to that of the Tm of calf thymus 
DNA versus the same ratio (Waring, 1974). Furthermore, the 
same similarity is observed for another intercalative com-
pound, acridine orange, which also increases the melting 
temperature of DNA (Kleinwachter and Koudelka, 1964) and 
inhibits the activity of DNA polymerase (Eberhard and Herr-
mann, 1972). 
In addition, it appears that the size of the sub-
sti tuent at position 6 of the phenanthridinium ring may also 
play a role in determining the extent of polymerase inhibi-
tion by the phenanthridinium derivatives. Indeed, small 
differences are observed in the inhibitory effect of these 
compounds on the activity of DNA polymerase; these differen-
ces suggest that 6-phenyl-substituted drugs are slightly 
more effective inhibitors than the derivative with a rela-
tively small ethyl group at position 6. Since no difference 
in the stabilization of DNA was observed between those com-
pounds, the slightly stronger inhibitory effect of the 
6-phenyl derivatives may be related to the presence of the 
bulky phenyl substituent, which projects into the major groove 
of DNA and which may impede further the propagation of the 
enzyme along the template. 
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3.4. Some biological implications of the inhibition of DNA 
polymerase 
As early as 1957, it was observed that DNA synthesis 
in certain organisms is drastically inhibited in the presence 
of EB (Newton, 1957). In addition, inhibition of mitochon-
drial DNA synthesis by EB has been reported in a variety of 
organisms (Riou, 1967b; Goldring et al., 1970; Radsak et al., 
1971). In many cases, inhibition of DNA synthesis is accom-
panied by alterations in the morphology and physiology of 
the organism under study (Riou, 1967a; Nass, 1970; Heilporn 
and Limbosch, 1971; Goldring et al., 1971). It is likely, 
therefore, that inhibition of DNA polymerase may be a major 
factor influencing the biological activity of the phenan-
thridinium compounds on the molecular level. · However, the 
role of DNA polymerase I in DNA replication has not been 
unequivocally established. It has been suggested (Okazaki 
et al., 1971) that this enzyme serves to close the gaps in 
the daughter strand of the DNA which result from the dis-
continuous DNA synthesis (Okazaki et al., 1968). Also, it 
is believed that DNA polymerase I participates in the repair 
of UV-induced damage to the nucleic acid (Harwood and Wells, 
1970; Hamilton et al., 1974). 
Evidence compatible with both of these hypotheses 
was obtained recently. The mitochondrial DNA of HeLa cells 
grown in the presence of EB is fragmented into pieces which 
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are approximately one-tenth the size of the original DNA 
molecule (Koch, 1973). Since, unlike nuclear DNA, the mito-
chondrial DNA of mammalian cells is continuously degraded 
and replaced by newly synthesized mitDNA (Gross et al., 
1969; Koch, 1972), two interpretations were advanced to 
account for this fragmentation of mitDNA in the presence of 
EB. It may be assumed that the mitDNA is normally subject 
to single stranded nicks which are subsequently closed by a 
DNA polymerase I-like enzyme, According to this mechanism, 
EB inhibition of this enzyme results in the accumulation of 
mitDNA fragments. Alternatively, it may be assumed that 
nicking constitutes part of the normal degradation process 
for mitochondrial DNA; EB then is believed to act by inhibit-
ing a DNA polymerase that is reponsible for the de !!QYQ. 
synthesis of mitDNA (Koch, 1973). 
Furthermore, EB was found to inhi~it the host cell 
mediated reactivation of UV-irradiated bacteriophage Tl as 
well as to enhance UV-induced mutation rate and lethality 
in h coli possessing the dark repair mechanism (Shankel a·nd 
Molholt, 1973). Host cell reactivating ability and resis-
tance to UV radiation were repeatedly associated with the 
presence of active DNA polymerase I (DeLucia and Cairns, 
1969; Kato and Koudo, 1970; McPhee, 1974) indicating that one 
of the biological functions of this enzyme is the repair of 
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UV-induced DNA damage. It is conceivable, therefore, that 
the observed increase in UV sensitivity of ~ coli and 
bacteriophage Tl in the presence of EB is due to inhibition 
by the dye of the activity of DNA polymerase I. 
SUMMARY 
Ethidium bromide (EB) and some of its analogs are 
known to bind to DNA by intercalation and preferentially 
stabilize its double-stranded form, as indicated by the 
increased Tm values noted for the resulting complexes. 
Hydrophobic forces between the phenanthridinium rind and 
the DNA bases are major contributors to the binding. Bind-
ing parameters for the 3,8-diamino derivatives are slightly 
higher than those for the 3-monoamino compounds, indicating 
that hydrogen bonds between the 3- and 8-amino groups and 
the DNA phosphate residues confer additional stabilization 
to the complex. This conclusion is further reinforced by 
the observed decrease in binding parameters at high ionic 
strength. 
Examination of the CD spectra of the phenanthridi-
nium-DNA complexes reveals several bands in the 300 - 600 run 
region. Molar ellipticities in the long (470 - 500 run) 
band are independent of complex concentration; therefore, 
optical activity in this region may be ascribed to the in-
fluence of the asymmetric environment of the binding site 
on the intercalated molecule. 
The molar ellipticity near 310 run increases with 
increasing bound dye/nucleotide ratio (r), indicating that 
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optical activity at this wavelength depends on the "popula-
tion density" of bound molecules. Since the CD of the 
EB-DNA complex near 310 nm exhibits, at least at high ionic 
strength, an exciton doublet, the optical activity of the 
diamino phenanthridinium-DNA complexes at this wavelength 
may be attributed to direct interactions between dye mole-
cules intercalated at neighboring sites. 
In the case of the monoamino dye-DNA complexes, a 
significant and gradual modification of the overall shape 
of the CD spectrum takes place with increasing r. The 
distinctly different behavior of the CD of the monoamino 
dye-DNA complexes suggests a different orientation of these 
compounds within their binding sites. This may result from 
the inability of the monoamino derivatives to form a second 
hydrogen bond with DNA residues. 
Differences in the positioning of the intercalated 
molecules are also indicated by the differences in the 
enhancement of the fluorescence intensity of the mono- and 
diamino derivatives upon binding to DNA. The fluorescence 
intensity of the diamino derivatives increases 20- to 30-fold 
upon complexing with DNA, whereas a small, if any, increase 
is observed with the monoamino compounds. The increase in 
fluorescence intensity of the dye is attributed to the 
influence of the hydrophobic environment of the interior of 
the DNA on the intercalated molecule. The much smaller 
increase in fluorescence of the monoamino dyes indicates 
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that the exposure of these compounds to the aqueous medium 
is more pronounced than that of the diamino derivatives. 
This assumption is consistent with the inability of the 
monoamino dyes to form a second hydrogen bond with DNA 
phosphate residues. 
Differences in the conformation of the complexes 
of DNA with the phenanthridinium dyes are also consistent 
with the pattern of inhibition of DNase I and DNA polymerase 
I by these compounds. The finding that, in both cases, the 
inhibition if overcome by increased DNA concentration, 
suggests that inhibition results from the binding of the 
drugs to DNA rather than from direct drug-enzyme interactions. 
The inhibition of DNase by the phenanthridinium dyes is 
probably due to an alteration in the conformation of the 
substrate leading to a decrease in the affinity of the en-
zyme for it. In contrast, a stabilization of the double- · 
stranded form of the template may be an important factor in 
the inhibition of DNA polymerase, since strand separation 
is a prerequisite for the action of this enzyme. 
For both enzymes, 6-phenyl compounds are slightly 
more effective inhibitors than the 6-methyl or 6-ethyl 
substituted derivatives. It appears that a bulky group at 
position 6 of the phenanthridinium ring increases the effec-
tiveness of the inhibitor by sterically preventing the 
binding and/or the propagation of the enzyme on the substrate 
or the template. 
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